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Abstract 
Application of micronisation (particle size reduction) in food industry is a novel 
technology introduced in recent years to modify the physico-chemical and biological 
characteristics of food components. Mushroom sclerotia of Pleurotus tuber-regium 
(PTR) were milled by ball milling to different particle sizes: 10 |Lim, 60 jiim, 200 ^m 
and these powders were extracted by hot water sequentially to obtain three hot 
water-soluble polysaccharides (PTR extracts) designated as lOPTR-1, lOPTR-2, 
lOPTR-3, 60PTR-1, 60PTR-2, 60PTR-3, 200PTR-1, 200PTR-2 and 200PTR-3, 
respectively. 
The average yield of PTR extracts increased as particle size decreased (6.80, 11.6 
and 36.1 % for 200PTR, 60PTR and lOPTR, respectively). The average carbohydrate 
content of PTR extracts increased as particle size decreased (60.1, 73.9 and 80.9 % for 
200PTR, 60PTR and lOPTR, respectively). The average protein content of PTR 
extracts decreased as the particle size decreased (39.0, 25.7 and 10.7 % for 200PTR, 
60PTR and lOPTR, respectively). The acidic sugar content was found to be low in all 
the extracts (lower than 4 %). All PTR extracts consisted of glucose and mannose 
with glucose being the most dominant monosaccharide (more than 90 %). The 
average mannose content of the PTR extracts decreased as particle size increased, 
which was consistent with that of the protein content，indicating the presence of 
mannoprotein. Three fractions of molecular weight ranging from 7.8 x lO"^  Da to > 
78.8 X 104 Da and 9.23 x lO"^  Da to > 78.8 x lO"^  Da were found in 200PTR-1 and 
200PTR-2, respectively. Only a single fraction was found in the three extracts of 
lOPTR with a molecular weight > 78.8 x ICA 
Except 60PTR-2, all the PTR extracts showed significant in vitro 
antiproliferative effect on human acute promyelocytic leukemic cells (HL-60) {p < 
0.05). Except 200PTR-1, all the PTR extracts showed significant antiproliferative 
effect on acute monocytic leukemia THP-1 cells {p < 0.05). Antiproliferative effect of 
the PTR extracts was not significant towards breast cancer cell (MCF-7) and chronic 
myelogenous leukemia cell (K562). Only lOPTR-3 showed significant 
antiproliferative effect towards murine sarcoma cells (SI80) {p < 0.05). 
All 3 fractions of lOPTR showed a dose-dependent inhibition when treated with 
THP-1 for 72 hours with an IC50 value of 269.8, 441.6 and 105.8 |Lig/mL, respectively 
and a significant increase in the sub-Gi apoptotic peak was observed at 24, 48 and 72 
hours (p < 0.05). 
iii 
lOPTR-1 and lOPTR-3 showed a dose-dependent inhibition when treated with 
HL-60 for 72 hours with an IC50 value of 250.79 and 266.78 fig/mL, respectively and 
a significant sub-Gi apoptotic peak was observed at 24, 48 and 72 hours {p < 0.05). 
The Bax / Bcl-2 ratio was elevated in a time-dependent manner in 1OPTR-1-treated 
HL-60 cells, indicating that the apoptosis probably the mitochondrial pathway was 
activated by lOPTR-1 treatment. 
In vivo studies demonstrated that lOPTR-3 showed significant inhibition on 
tumor weight of S-180 tumor grown on BALB/c mice at a dose of 20 mg/kg (54.85%, 
p<0.05). lOPTR-1 and lOPTR-3 showed significant inhibition on tumor volume of 
HL-60 tumor grown on athymic nude mice at a dose of 10 mg/kg (33 and 36 %, 
respectively, ；7<0.05) whereas only lOPTR-3 showed significant inhibition at the same 
dose in terms of tumor weight (38 %,/><0.05). 
Micronisation can effectively increase the yield of extracts from PTR sclerotia 
and these PTR extracts contain polysaccharide-protein structure that possess in vitro 












量分別為6.80 ’ 11.6和36.1%) °隨著顆粒大小減少，PTR萃取物的平均碳水化 
合物含量也增加（200PTR，60PTR和10PTR的平均碳水化合物含量分別為 
60.1' 73.9和80.9%);而且平均蛋白質含量也相應減少（200PTR，60PTR和10PTR 




和200PTR-2分別由三個部份組成，分子量分別由7.8 x 1 0 4至� 7 8 . 8 x 104及由 
9.23 X 104至〉78.8 x lO4�三種來自10PTR的萃取物都只由一個部份組成，分子 
量都是 > 78.8 X 104� 
除了 60PTR-2，所有PTR萃取物在體外能有效地抑制人體急性白血病細胞 
(HL-60)的生長（P < 0 . 0 5 ) �除了 200PTR-1，所有PTR萃取物在體外能有效地抑 
制急性單核細胞白血病細胞（THP-1)的生長（P < 0 .05)�但是PTR萃取物對人體 
乳腺癌細胞(MCF-7)和慢性骨髓性的白血病細胞(K562)沒有很大的抑制作用。另 
夕卜，只有10PTR-3對鼠科肉瘤細胞（S180)有明顯的抑制作用（p<0.05)� 
10PTR-1, 10PTR-2 和 10PTR-3 在 269.8，441.6 和 105.8 pg/mL 的濃度下能有 
效將THP-1的生長減低一半。流動細胞儀檢測結果顯示這三種萃取物均能引起 
THP-1 的細胞程式死亡（Apoptosis) (P < 0.05)� 
10PTR-1和10PTR-3分別在250.79和266.78 pg/mL的濃度下能有效將HL-60 





(54.85% ’ p< 0.05)�在裸體老鼠實驗中’ 10PTR-1和10PTR-3能有效地抑制HL-60 
腫瘤容量（分別為33%，p< 0.05和36% ’ p< 0 .05)�10PTR-3也能有效地抑制 
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Chapter 1 Introduction 
1.1 Introduction on mushroom life cycle 
Mushroom is generally referred as the fruiting body of a macrofungus which is 
large enough to be seen with naked eyes. Among the 10000 mushroom species 
worldwide, about 700 is edible, 50-20 are medicinal and 50 are poisonous. Six genera 
of mushrooms cover 90% of world production, namely: Agaricus, Lentinula, 
Pleurotus, Auricularia, Volvariella and Flammulina. Mushroom is a nutritive food 
source rich in vitamins, minerals and dietary fibre. Bioactive molecules like 
terpenoids, steroids, phenols, nucleotides, glycoproteins and polysaccharides are also 
found in mushrooms (Borchers, 1999). 
Fruiting body, with a distinctive stipe (stalk) and pileus (cap), is a mycelial 
network with spore-producing function. Spores called basidia produced in pileus can 
germinate to give filamentous cells called hyphae. Hyphae grow by extending at the 
tip to form a primary mycelium. When two hyphae meet and fuse with one another, 
genetic material combined and a larger secondary mycelial network which grows 
much faster is formed. Side branching of mycelium results in thickening of the 
mycelium (Stamets, 1993). 
In response to environmental stimuli, for example a change of humidity and 
intensity of light, mycelium is triggered to transform to fruiting body through a 
mechanism known as “biological switch". Mycelium first grows into primordia by 
increasing in density and rearranging in a homogeneous way, then primordia mature 
when a suitable environment prevails. As mushrooms grow and differentiate, walls 
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and septae form, cap, stem, veil and gills emerge. Spores are produced by 
spore-producing cells called basidia on the surface of gills which are protected by a 
cap. The mushroom life cycle completes when spores are released and grow into 
mycelium. 
1.2 Introduction of mushroom sclerotium 
Mushroom sclerotium is an effective strategy for the survival of Ascomycetes 
and Basidiomycetes. (Carlile et al., 2001). In times of adverse weather or condition, 
like drought and winter, in order to survive, the mushroom species enters the dormant 
phase of the life cycle, producing sclerotia (Stamets, 1993; Wasser and Weis, 1999). It 
is an important life stage of mushroom which act as a resting structures to remain at 
the site of production (Carlile et al” 2001). One of the most common sclerotia is from 
Poria cocos (called “Fuling，，in China) that is widely used in Chinese soup. 
Sclerotium is usually spherical in shape and about a millimeter to a centimeter in 
diameter (Carlile et al., 2001). It is a fungal mass of hyphae which has a hardened 
tuber, wood-like texture (Hoffman, 1999). The central medulla part of sclerotia 
consists of thin-walled cells with abundant lipid and glycogen reserves. (Carlile et al., 
2001). This nutrient- and chemical-rich inner part helps it to overcome the undesirable 
conditions and even survive for many years, (Hoffman, 1999). Outside there is 
thickened wall consisting of dead cells impregnated with melanin (Carlile et al., 
2001) which gives sclerotia wood-like texture. Germination of sclerotium is triggered 
by different stimulus in different species. Return of favorable conditions of light and 
temperature, exposure to nutrients or stimulation by substances emitted by a host 
plant can result in arise of mushrooms or mycelia from scletoium. (Carlile et al., 
2001). 
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1.3 Different extraction methods of mushroom polysaccharides 
Mushroom polysaccharides are structural components of fungal cell wall. There 
are two major types of polysaccharides: rigid fibrillar of chitin (or cellulose) and 
matrix-like beta-glucan, alpha-glucan and glycoproteins (Ruiz-Herrera, 1956). To 
extract the cell wall polysaccharides from the insoluble cell wall material, different 
extraction methods can be used. 
Extraction is the isolation of high molecular weight substance and elimination of 
low molecular weight substances from mushroom material. It involves the breaking of 
the outer and inner layer of the cell wall of different solvent and extraction conditions 
(e.g. pH and temp). As a result, polysaccharides with different structural 
characteristics will be obtained. 
The selection of extraction method depends on the cell wall structure. Water at 
various temperature is usually the first choice for extraction of neutral 
polysaccharides (Izydorczyk, 2005). Hot water extraction is a popular approach to 
obtain water-soluble polysaccharides. Extraction with alkali solutions yields 
water-insoluble ones (Zhang et al., 2007), but it was suggested that once the 
polysaccharides released from the cell wall, they become soluble (Izydorczyk, 2005). 
Apart form chemical methods, physical methods such as ultrasonication of which 
high-energy sound waves are used to degrade the fungal cell wall polysaccharide are 
often adopted. Hot and cold alkali, as well as sonication，have been used to extract 
antitumor polysaccharides from sclerotia of Pleurotus tuber-re gium, Poria cocos and 
Polyporus rhinoceros successfully (Lai, 2005). 
3 
1.4 Bioactivities of mushroom polysaccharides and factors affecting their 
biological activities 
Mushroom polysaccharides being a class of macromolecules with enormous 
structural variety (Wasser, 2002), demonstrate many kinds of biological activities, 
namely hypocholesterolemic, antiviral, antibacterial, antiparasitic, antidiabetic, 
hepatoprotective and antitumor effects (Wasser and Weis, 1999). Structural 
composition such as molecular weight, protein content, solubility, branching unit and, 
linkages and helical conformation would affect the biological activities. 
1.4.1 Molecular weight 
It is generally recognized that high molecular weight glucans of mushroom 
polysaccharides appear to be more effective than those of low molecular weight 
(Wasser, 2002; Mizuno et al., 1996). It is suggested that (1^3)-P-D-glucan, with 
molecular weight higher than 90,000，appears to be in helical form in aqueous media 
and exhibits high Sarcoma 180 growth-inhibiting activity (Bohn and BeMiller, 1995). 
On the other hand, a p-glucan with a molecular weight of 20,000 has neither helical 
structure in aqueous solution nor significant antitumor effect. (Blaschek et al., 1987). 
Effect of molecular weight can also be observed by a change of biological activities in 
fractions of polysaccharides of various molecular weight found in Grifola frondosa 
(Adachi et al., 1990). However, both high and low molecular weight fractions 
(ranging from 220-3.5kDa) of acidic heteroglycans from Tremella fuciformis Berk 
induced in vitro IL-6 cytokines production in human monocytes, suggesting that the 
moleculer weight of polysaccharide had no obviously influence on the cytokine 
stimulating activity (Gao et a/., 1996). Therefore, more investigation is needed to 
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establish an explicit relationship between biological activities and molecular weight. 
1.4.2 Linkages 
Generally (1^3)-P-linkages in the backbone of the glucan and additional 
(l->6)-P-branch points are referred as one of the important structural features for 
antitumor action. On the contrary, p-glucans with mainly (1+6) linkages in backbone 
have less activity, possibly due to due to their inherent flexibility of having too many 
possible conformation (Mizuno et al., 1995, Zhang et al., 2007). Moreover, 
hetero-P-glucans, (Mizuno et al., 1995) heteroglycan (Gao et al., 1996), 
P-glucan-protein (Kawagishi et al., 1990), a-manno-P-glucan (Mizuno et al., 1995), 
a-glucan-protein (Mizuno et al., 1995) and heteroglycan-protein complexes (Mizuno 
et al” 1996; Zhuang et al” 1993) are also found to be antitumor polysaccharides. This 
is particularly observed in the case of curdlan (an unbranced (1—3)-P-glucan) and 
lichenan (a mixed linkage of l->3 and 1^4)-|3-glucan), when both of them were 
modified with various branching group added to oxygen in the carbon position, 
curdlan showed much more potent inhibition against Sarcoma 180 tumors than 
lichenan (Matsuzaki et al., 1986). 
1.4.3 Branching rate 
Degree of branching (DB), the ratio of occurrence of branches to the main chain 
unit (Yadomae and Ohno, 1996), is another important factor which determines the 
immunomodulatory activity of mushroom polysaccharides. An optimum branching 
ratio is crucial for stronger bioactivity. It is suggested that those with DB between 
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0.20-0.33 seem to be most active (Bohn and BeMiller, 1995). Lentinan, which has 
significant inhibitory effect on Sarcoma 180 tumors, showed higher activity after 
being partially debranched with sodium periodate (Sasaki and Takasuka, 1976). 
Pachyman, a branched polysaccharide from Poria cocos which has no antitumor 
activity, exhibited high activity after the branches were partially removed (Chihara et 
(7/., 1970; Narui et al., 1980). Curdlan, which is a linear unbranched (1^3)-P-glucan, 
showed no inhibition towards Sarcoma 180 tumors unless modified by substitution of 
its glycosyl branch units. The antitumor activity is regardless of the type of glucosyl 
units being substituted (Demleitner et al., 1992). 
1.4.4 Conformation 
Secondary structure of polysacharides plays an important role in determining its 
bioactivity. Different extraction and isolation method may result in p-glucan with 
different conformation. There are 3 types of secondary structures: triple helix, single 
helix and random coil (Mizuno et al., 1995). Branched (1^3)-p-glucan has triple 
helix conformation in aqueous solution while linear (l->3)-|3-glucan of intermediate 
chain length have random coil conformation (Mizuno et al., 1995). P-glucan with low 
molecular weight is stabilized in aqueous media like hot water or aqueous alkaline 
solution by adopting a random coil conformation (Yadomae and Ohno, 1996). A 
triple-helical conformation of medicinal mushroom (1^3)-P-glucan is known to be 
important for their immunostimulatory activity (Wasser, 2002). Triple-helical lentinan 
exhibited much higher in vivo and in vitro antitumor activities than its single flexible 
chain counterpart (Zhang et al., 2005; Surenjav et al., 2006); It is also reported that 
only triple-helical schizophyllan is active (Kojima et al, 1986) while low molecular 
weight schizophyllan has no helical structure and antitumor activity (Bohn and 
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BeMiller, 1995). High ordered structures (triple helices) of high moleculaer weight 
(1^3)-P-glucans are responsible for their immunomodulating activity and only higher 
molecular weight fraction (>90,000) form triple helical structures (Saito et al., 1977, 
1991). 
1.5 Mechanisms for antitumor activites of mushrooms polysaccharides 
There are three proposed mechanisms by which mushroom polysaccharides exert 
antitumor effect (Zhang et al” 2007; Huang et al., 2007). 
1.5.1 Cancer-preventing activity 
The cancer-preventing activity refers to the prevention of oncogenesis by oral 
administration of polysaccharides isolated from medicinal mushrooms (Zhang et al., 
2007). Epidemiological data indicated 40 % lower cancer death prevalence in farmers 
growing Flammulina velutipes in Japan and Agaricus blazei in Brazil (Ikekawa, 2001). 
A consequent animal study also revealed that the treated mice group fed with 
mushroom polysaccharides from F. velutipes and A. blazei before inoculation of 
tumor had less tumor-bearing mice than the control mice group which were fed with 
normal mice diet (Ikekawa, 2001). 
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1.5.2 Immuno-enhancing activity 
Mushroom polysaccharide can exert their antitumor effects by activation of the 
host immune system. Since they exert a nonspecific action on the host, they are often 
referred as biological response modifiers (BRM). According to Wasser and Weis 
(1999), the critieria for BRM are: 
• It should cause no harm to and place no additional stress on the body; 
• It should help the body adapt to various environmental and psychological 
stresses; 
• It must have a nonspecific action on the body, supporting all the major 
systems, including nervous, hormonal and immune systems, as well as 
regulating functions. 
1.5.3 Direct tumor inhibition activity 
In recent years, direct tumor inhibition activity of mushroom polysaccharides can 
be observed from in vitro studies when mushroom polysaccharides are incubated with 
tumor cell lines. The direct cytotoxicity of polysaccharides on tumor cell lines 
involves alternation of the cellular signals such as cytokines and cyclins and result in 
cell cycle arrest or apoptosis. Polysaccharide-peptide complex (PSP) extracted from 
Trametes versicolor; and protein bound polysaccharide (PBP) extracted from 
Phellinus linteus have antiproliferation effect on MAD-MB-231 breast cancer cells 
and SW180 human colon cancer cells, respectively (Chow et al., 2003; Li et al., 
2004). A water-soluble mushroom polysaccharides extracted from mycelia of Poria 
cocos is also reported to exhibit strong in vitro antitumor activities against HL-60 
tumor cell (Huang et al., 2007). 
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1.6 Cell cycle regulation and induction of apoptosis 
1.6.1 The cell cycle machinery 
Cell cycle is a series of highly coordinated events which regulates rate of 
proliferation and growth of cells. As stated by Howard and Pelc (1953), cell cycle is 
comprised of DNA synthesizing S phase and mitotic M phase, separated by gaps 
called Gi and G2. Most cells are non-dividing and stay in quiescent state known as Go 
(Schwartz and Shah, 2005). Upon stimulation of growth factors, the cells will pass 
through Gi, S, G2 and M phases to complete cell growth (Figure. 1.1). 
Transition from one phase to another through checkpoint is governed by 
cyclin-dependent kinases (CDKs) which are serine/ threonine protein kinases (Collins 
and Garrett, 2005; Vermeulen et aL, 2003). CDKs are regulated positively by cyclins 
and negatively by naturally occurring cell cycle inhibitory proteins CDK inhibitors 
(CDKIs). The levels of activating cyclins in different stages of the cell cycle differ 
whereas the CDK protein levels remain stable (Vermeulen et aL2003). Expression 
pattern of cyclins defines the progression of cells through cell cycle. There are at least 
nine CDKs (CDK1-CDK9) and a number of cyclins (cyclin A-T) that have been 
identified. CDK/cyclin complexes are activated by cdk7/cyclin H which is referred as 
CDK-activating kinase (CAK) (Schwartz and Shah, 2005). 
Most cells in the body are non-dividing cells and are said to be in Go quiescent 
state. When a cell is activated by growth factors, it enters the cell cycle in Gi phase. 
During Gi phase, the cell is preparing for DNA synthesis and it is in diploid state with 
2n chromosomes (Collins and Garrett, 2005; Schafer, 1998). Cyclin D isoform (cyclin 
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D1-D3) interact with CDK4,-6 and drive the cell through Gi phase (Schwartz and 
Shah, 2005; Vermeulen et al., 2003). For Gi/S transition to proceed, cyclin E with 
CDK2 controls entry into S phase. During S progression, DNA duplication occurs 
under the influence of cyclin A/CDK2 complex. At the end of S phase, 4n 
chromosomes result. In Gi phase, cyclin A/CDKl (cdc2) helps cell growth and 
prepares for cell division. In the mitotic M phase, cyclin B/CDKl is important for the 
separation of cell into two daughter cells (Coqueret, 2003, Schwartz and Shah, 2005). 
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Figure 1.1 The cell cycle and key regulators. 
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1.6.2 Cell cycle arrest and regulation 
Cell cycle progression is important in controlling cell growth, cell proliferation 
and regulation of DNA repair. Checkpoints in cell cycle arrest of cell growth and 
allow repair mechanisms to happen. Cancer is caused by dysregulation of cell cycle in 
which cyclins overexpressed or CDKIs are inhibited resulting in uncontrolled cell 
growth. (Maddika et al., 2007). 
Gi/S transition, S phase and G2 phase are checkpoints which tightly regulate cell 
cycle progression (Pommier et al., 2002). p53 and pRb are tumor suppressor protein 
that are closely related to Gi/S transition. p53 is known as the “ guardian of genome” 
(Potten and Wilson, 2004) as it is also involved in apoptotic pathway. Depending on 
the severity of cellular stress such as DNA damage, hypoxia and oncogene activation, 
growth arrest genes (low level cell injury) or even apoptotic pathways (severe cellular 
stress) will be initiated with the mediation of p53 (Schwartz and Shah, 2005). These 
responses are carried out via the ability of p53 to function as a transcription factor: It 
(a) mediates cell growth arrest by inducing the expression of p21, 14-3-3s, Cdc25C, 
and GADD45; {b) stimulates DNA repair by inducing the expression of p21, 
GADD45, and the p48 xeroderma pigmentosum protein; and (c) induces apoptosis by 
upregulating the transcription of Bax, PUMA, Noxa, p53-AIP, PIG3, 
Fas/AP01/CD95, and KILLER/DR5 (Maddika et al, 2007). 
Rb, the retinoblastoma tumor suppressor gene was the first suppressor gene 
identified (Lee et al, 1987). pRb works closely with E2Fs during cell cycle (Figure 
1.2). When it is hypophosphorylated, it is activated and forms inhibitory complex 
with transcription factors known as E2F-DP (E2F1, -2, -3) (Hsieh et al., 2002; 
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Jackson and Pereira-Smith, 2006) and inhibit proliferation of cell cycle. 
Phosphorylation of pRb is modulated by CDK4/6-cyclin D and CDK2/cyclin E. 
Activated by mitogenic factor, pRb is partially phosphorylated by CDK4/6-CDKs and 
bind to E2F-DP, but the transcription factor is still able to transcribe some genes such 
as cyclin E. Cyclin E binds to CDK2 and completely phosphorylates pRb, it then 
releases E2F-DP complex and fully activate E2F transcription factors which are 
important for cell cycle progression. 
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Figure 1.2 The G\/S transition and retinoblastoma protein (Rb) 
During S phase progression cyclin D and E are targeted by ubiquitination for 
proteosome degradation, production of cyclin A which with CDK2 allows S phase 
progression with inactivation of E2F, partly completed by cyclin A-dependent kinase 
activity. Cyclin A/CDK2 associates with E2F/DP heterodimer and neutralize its DNA 
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biniding capacity. 
Cyclin A and B levels increases in late S phase for preparing mitosis, a 
replication checkpoint (Zhou and Elledge, 2000; Xu et al., 2001) is reached which 
monitors S phase progression and slow ongoing DNA synthesis. Cyclin B/CDKl 
complex are activated by phosphorylation by CAK. The complex relocates into 
nucleus and begins mitosis. When there is unrepaired DNA damage, G2 checkpoint is 
initiated by inactivation of cyclin B/ CDKl and halts further cell cycle progression 
(Kastan and Bartek, 2004). 
M phase progression depends on anaphase-promoting complex (APC)/ 
cyclosome and degradation of cyclin B (Ford and Pardee, 1999). Survivin is important 
in regulation of mitotic spindle and in preservation of cell vialibity. Cyclin Bl/CDKl 
activity during mitosis plays a critical role in surviving expression and function in cell 
viability (Maddika et al” 2007). 
1.6.3 Apoptosis and regulation 
Apoptosis is programmed cell death for the aim of removal of cells that are 
produced in excess (e.g. to remove excess T cells after infection), with improper 
development or having DNA damage that cannot be repaired. It is characterized by an 
absence of inflammatory response because the contents of the apoptotic cells would 
be absorbed by neighbouring cells (Baguley, 2002; Fesik, 2005). There are two 
pathways for apoptosis, namely the extrinsic death-receptors-dependent pathway and 
intrinsic mitochondria pathway (Figure 1.3). 
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Figure 1.3 Extrinsic and Intrinsic pathways of apoptosis 
Caspases (Cysteine aspartic acid proteases) is the group of endogenous 
proteins which is activated for degradation of cellular components despite of the kind 
of pathway (extrinsic or intrinsic) induced. Caspases are produced as pro-enzyme and 
have to be activated by proteolysis by autoactivation or other caspases. There are 2 
types of caspases involved in apoptosis (Lawen, 2003): 
(1) The initiator caspases (e.g. caspase-8 and caspases-10) can cleave procaspases and 
activate the effector/ executioner caspases. 
(2) The effector/ executioner caspases (e.g. caspases-3, caspases-6 and caspases-7) 
can degrade protein cellular structure and results in apoptosis (Lawen, 2003). 
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The extrinsic/ receptor-mediated pathway is based on ligation of cell surface 
receptors for signaling (Figure 1.3). An example of extrinsic pathway is Fas-mediated 
pathway. Fas (or called CD95/ Apo-1) receptors is a member of the TNF-R family. 
When FasL is present and binds to Fas, adaptor proteins FADD (Fas-associated death 
domain protein) bind to Fas through the cytosolic death domain of Fas. Procaspase-8, 
possessing a (DED) death effector domain, binds to DED of FADD. The four 
components, Fas, FasL, FADD and procaspase-8 together form a complex death 
inducing signaling complex (DISC). Procaspase-8 of the complex activates other 
procaspase-8 molecules by transactivation. Active caspase-8 would (1) directly cleave 
executioner caspases like caspase-3 to degrade cellular structures. (2) cleave the Bid 
protein which then translocates to the mitochondria and induce cytochrome release 
(Lawen, 2003). 
Another example of extrinsic pathway is the TNF-mediated pathway. One of the 
receptor involved is the TNF-R (tumor necrosis factor receptor). Like Fas, TNF-R 1 
are of TNF-R family and contain a cytosolic death domain (DD). TNF-a binds to 
TNFaR and triggers the downstream effectors. 
The intrinsic / mitochondria dependent pathway is mediated by the balancing ratio 
of proapoptotic and antiapoptotic factors. Bcl-2 family is subdivided into three kinds 
according to their Bcl-2 homology (BH) domains, comprising of both proapoptotic 
and antiapoptotic factors. Bax and Bad are proapoptotic while Bcl-2, Bcl-xL are 
antiapoptotic. Bcl-2, Bcl-xL works against Bax (Lawen, 2003). 
Bcl-2, being the first survival death genes recognized (Potten and Wilson, 2004), 
is a gene product of B-cell lymphoma 2 gene, (bcl-2). Bcl-2 level is usually found to 
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be overexpressed in many tumors (Cory and Adams, 2002), and render the cell to 
become more resistant to apoptosis. 
Bax, known as Bcl-2- associated X protein, exerts its proapoptotic effect by 
binding to Bcl-2 proteins. The Bax/Bcl-2 molecule will help to release 
apoptosis-inducing factors from mitochondria (Potten and Wilson, 2004). 
Cytochrome c is one of the typical example of apoptosis-inducing factors 
released from mitochondria upon an increase in the ratio of proapoptotic to 
antiapoptotic factors. Cytochrome c binds to apoptotic protease activating factor 
(Apafl) and form apoptosome. Apoptosome activates procaspases-9 by binding to it 
and the complex can activate other effector caspases to perform apoptosis (Lawen, 
2003; Thompson, 1995). 
1.7 Literature review on Pleurotus tuber-regium 
1.7.1 Introduction of Pleurotus tuber-regium 
Pleurotus tuber-regium is a fungus that is found mainly in southern China, 
Myanmar, and some other south-eastern Asian countries. It is used as a medicine for 
the treatment of coughs and asthma in some folk recipes (Deng et al.,2000). The 
fruiting body of PTR is high in protein (Kadiri and Fasidi, 1990) while its sclerotium 
has over 80% dietary fibre, especially non-starch polysaccharides (Cheung and Lee, 
1998). It is reported that more than 60% dry weight of the PTR sclerotium is bioactive 
p-glucan (Cheung and Lee, 2000). Sulfated P-glucans from Pleurotus tuber-regium 
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has been reported to show an effective antiviral activity against herpes simplex virus 
type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) (Zhang et al., 2004a), 
besides, antitumor activity of polysaccharides extracted from different stages of PTR 
has also been investigated widely. 
1.7.2 Antitumor effect of mushroom polysaccharides isolated from different 
developmental stages of Pleurotus tuber-regium 
1.7.2.1 Sclerotium 
Polysaccharides in PTR sclerotia extracted under different conditions result in 
different structure characteristics and bioactivity. In a study of antitumor activity, 
different media were used to extract the PTR sclerotia polysaccharides. Hot water 
extract of PTR sclerotia showed a significant inhibition of 55.3% of SI 80 solid tumor 
growth in BALB/c mice while sonication-extracted fraction only have 30% inhibition 
without statistical significance when compared with the control (Zhang et al., 2004c). 
It seemed that hot water extraction is a better method for extraction of antitumor 
polysaccharides from PTR sclerotia. 
To achieve a higher yield of polysaccharides, a more vigorous extraction 
condition was applied. High temperature and alkaline condition were used in a study 
to extract antitumor polysaccharides from PTR sclerotia. The hot alkali 
polysaccharides of PTR sclerotia (HAE) extracted by autoclaving at 121°C were 
found to adopt a random-coil chain conformation in DMSO and possessed antitumor 
activities. The in vivo assays revealed that HAE with medium molecular weight 
(5.8-17.1 X 104) was effective to inihibit Sarcoma, S-180 in BALB/c mice (48%-76% 
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tumor size inhibition). In the in vitro assays targeting proliferation of human acute 
leukemia (HL-60) and human hepatocellular carcinoma (HepG2), hot alkali PTR 
fraction with higher molecular weight (5.8-42.2 x lO"^ ) showed a stronger inhibition 
than those with low molecular weight (1.0-2.2 x lO"^ ). The study also suggested that 
the antitumor activity of hot alkali soluble polysaccharides of PTR sclerotia is host 
mediated and cytocidal (Zhang, et al., 2001) 
Native hot alkali polysaccharides from PTR sclerotia have poor water solubility 
(Zhang, et al., 2001). Chemical modification such as carboxylmethylation, 
formylmethylation, aminethylation and sulfation can enhance water solubility of 
polysaccharides and their bioactivity (Ooi and Liu, 2000). In a study on the effect of 
carboxymethylation, hot alkali polysaccharides from PTR sclerotia (HAE) were 
modified by substituting the hydroxy 1 groups with carboxymethyl groups. The 
carboxymethylated hot alkali fractions from PTR sclerotia (CMHAE) have 
significantly enhanced in vivo inhibition of SI80 tumor on BALB/c mice and in vitro 
inhibition on HL-60 when compared to their corresponding native counterparts. It was 
also found that intraperitoneal administration of the CMHAE in BALB/c mice could 
increase production of tumor necrosis factor alpha (TNF-a) stimulated by 
lipopolysaccharide (LPS) (Zhang et al., 2004b), suggesting that the CMHAE fractions 
have stimulatory effect on the immune system. It is also found that the CMHAE 
fractions inhibit human breast carcinoma (MCF-7) cells by Gi phase arrest and 
apoptosis induction. The Gi phase arrest was associated with the down-regulation of 
cyclin D1 and cyclin E expressions while the apoptotic induction was associated with 
decreased expression of Bcl-2 protein (Zhang et al., 2006). 
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1.7.2.2 Mycelium 
Water-soluble polysaccharides from mycelium of PTR (EDP) inhibited the 
growth of HL-60 cells at 400|Lig/mL by apoptosis with an increased Bax/Bcl-2 ratio 
(Wong et al., 2007). Besides, an accumulation of cells at the G2/M arrest (16.3% of 
total cells) through lowering of Cdkl expression was observed after 24-hours 
incubation (Wong et al., 2007). Polysaccharides from mycelium of PTR also 
demonstrated in vivo antitumor effect. Water-soluble polysaccharides from mycelium 
of PTR resulted from hot water extraction exhibited a strong inhibition (65.4%) 
against Sarcoma 180 solid tumor in BALB/c mice while those from sonication 
method showed a weaker inhibition (30.8%) (Zhang et al., 2004c). It seemed that 
extraction method is one of the important factors that determines the antitumor 
activities of mushroom polysaccharides. 
1.7.2.3 Culture medium 
Water-soluble extracellular polysaccharides isolated from culture medium of 
PTR mycelia (CEP) significantly inhibited the growth of HL-60 cells with an 
approximate IC50 value of 300|ag/mL (Wong et al., 2007). It was found that CEP 
exerts its antitumor effect via apoptosis with a decrease of Bcl-2 protein in a 
time-dependent manner with an increase of Bax protein after 72-hours incubation 
(Wong et al., 2007). 
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1.7.2.4 Fruiting body 
Heteropolysaccharide-protein complex extracted from fruiting body of PTR 
(Figure 1.4) has strong cytotoxicity against HL-60 cells with an IC50 of 25iig/mL 
(Wong et aL, 2007). It was found that the PTR polysaccharide induces S arrest in 
HL-60 cells by depletion of Cdk2 and up-regulation of cyclin E. Apoptosis was also 
observed in the HWE treated HL-60 cells. The expression level of Bax protein was 
markedly increased at 24-, 48- and 72-hours while Bcl-2 protein was decreased in a 
time-dependent mannaer (Wong et al., 2007). 
H ^ H 
Figure 1.4 Fruiting bodies grown from a sclerotium of Pleurotus tuber-regium 
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1.8 Literature review on Size reduction process 
1.8.1 Introduction of micron technology 
Particle size reduction has aroused interest of scientists worldwide in recent 
years. Application of microtechnology or nanotechnology in food industry has gained 
much attention. The greater surface area per unit mass resulting from size reduction 
may render the particles to be more biologically active when compared with their 
larger-sized counterparts (Oberdo'rster, et al., 2005). The application of these 
emerging technologies in nutraceuticals and functional food have shown great 
potential for delivering bioactive substances to human body more effectively (Chen et 
al., 2006). 
Micronisation refers to the reduction of particle sizes of the material to 
micrometer scale. Various studies suggested that reduction of particle size can alter 
the structure, physicochemical and functional properties of the material. There are 
different micronisation techniques and equipment available. 
1.8.1.1 Ball milling 
For ball milling [Figure 1.5 (a)], the sample and grinding balls in a certain ratio 
are mixed in an grinding bowl. Grinding bowls and balls [Figure 1.5 (b)] can be made 
up of zirconium oxide, chromium steel, stainless steel, agate, etc., the choice of the 
material depends on the nature of the sample to be micronised. Usually for food 
materials, agate is used to prevent metal contamination. With quick rotation of the 
grinding bowl, grinding balls collide with samples resulting in particle size reduction 
(Chau et al., 2006; Chau et al., 2007a; Chau et al, 2007b). 
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(a) Ball mill machine (b) Grinding bowls and balls 
Figure 1.5 Ball mill 
1.8.1.2 Jet milling 
For jet milling, pulverization of the sample is carried out by a single passage 
through the milling chamber of a jet-mill using compressed air at a certain pressure 
(Chau et al., 2006; Chau et al., 2007a; Chau et al., 2007b). 
1.8.1.3 High-pressure homogenising 
A high-pressure homogenizer (Figure 1.6) is designed for continuous operation 
of microsizing test on different fluids. To operate a high-pressure homogeniser, the 
sample is micronised with distilled water at a high pressure. The sample solution is 
allowed to pass through the high-pressure microsizer once to several times, depending 
on the nature of sample. Then the micronised mixture is collected, freeze dried and 
kept in a desiccator until use (Chau et al, 2006; Chau et al., 2007a; Chau et al., 
2007b). 
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Figure 1.6 High-pressure homogenizer 
1.8.1.4 Oscillatory milling 
For oscillatory milling, size reduction is achieved by friction and impact resulted 
from oscillating rings and a cylinder (discs) inside a casing containing the sample. 
(Suraj, G eX a/., 1997) 
1.8.2 Effect of particle sizes on physicochemical properties and biochemical 
activities of plant materials 
Many studies on the effect of micronisation on plant material are carried out by 
the micronisation techniques described above. It was reported that micronisation has a 
positive effect on physiochemical properties and shows improvement in functionality, 
giving insight to their potential application in the food industry (Chau et al., 2007c). 
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1.8.2.1 Physicochemical properties 
A study of the effects of particle size of cocoa nibs on cocoa butter extraction 
revealed that the highest yield of cocoa butter was obtained with the smallest cocoa 
nibs (Asep et al., 2008). Studies on effects of micronisation on physicochemical 
characteristics on insolube dietary fibre fraction from orange peel and carrot pomace 
had found that the functionalities of the carrot insoluble fibre and orange peel from 
Citrus sinensis L. cv. Liucheng fibre were improved. In both experiments, the dietary 
fibre showed a decrease in bulk density, an increase in glucose adsorption capacity 
and improvement in physicochemical properties such as water-holding capacity, 
swelling capacity, oil-holding capacity and cation exchange capacity (Chau et al, 
2006; Chau et al., 2007a). A similar study of dietary fibre from sugarcane bagasse 
also showed that particle size reduction is positively correlated with water-holding 
capacity and oil-bindig capacity as well as negatively correlated with bulk density 
(Sangnark and Noomhorm, 2003). The quality of bread added with the size-reduced 
sugarcane bagasse dietary fibre also showed improvement in dough expansion, loaf 
volume, bread texture and sensory evaluation tests (Sangnark and Noomhorm, 2003). 
1.8.2.2 Biochemical activities 
Insoluble fibre can help alleviate the symptoms of diabetes by adsorbing glucose 
and decreasing the concentration of available glucose in the small intestine. They can 
also retard the activity of a-amylase and postpone the release of glucose from starch 
to help lower postprandial serum glucose level (Ou et al., 2001). Extracts from 
medicinal herbs have lipase-inhibiting activity and can be used to prevent undesirable 
changes in foods such as an off-flavour (Shimura et a/., 1992). In the study of dietary 
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fibre from orange peel (Citrus sinensis L. cv. Liucheng) and carrot pomace mentioned 
above, micronisation treatment such as ball-milling, jet-milling and high-pressure 
micronisation, could enhance the glucose adsorption capacity, a-amylase and 
pancreatic amylase inhibitory effects of the insoluble fibre-rich fraction (Table 1) 
(Chau et al., 2006; Chau et al., 2007a). It is proposed that micronisation treatment can 
increase the porosity; exposure of more amylase- and lipase- inhibiting substances on 
the fibre surface, and reduce accessibility of amylase to starch/ lipase to oil (Chau et 
al., 2006; Chau et al, 2007a). 
Table 1.1 Increase of a-amylase and pancreatic lipase inhibitory activity of the carrot fibre-rich 
fraction using different micronisation treatment (%) 
Enzyme inhibiting activity Micronisation treatment 
Ball milling Jet milling High-pressure micronisation 
a-Amylase inhibitory activity 260 220 370 
Pancreatic lipase inhibitory 
247 280 330 
activity 
Consumption of micronised fibre (10.3-20.9|im) of carrot insulobe fibre at 5 % 
level was found to exert a favourable effect on intestinal health-improvement in male 
Golden Syrian hamsters (Chau et al., 2007b). The micronised fibres, especially that 
prepared by high- pressure micronisation, significantly improve some caecal and 
faecal parameters in the intestinal lumen by decreasing caecal ammonia concentration, 
increasing faecal output and moisture content, and reducing the activities of undesired 
P-D-glucosidase and P-D-glucuronidase in faeces (Chau et al., 2007b). 
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Micronised carambola fibre exhibited higher oil-holding capacity (about 
20.4-fold) and vitamin E carrying capacity (about 9.6 fold) than their unmicronised 
forms in in vitro study. Animal study also revealed that micronised carambola could 
maintain the plasma vitamin E of rats at higher levels than the initial values. This 
result showed that micronisation could improve the nutrient carrying ability of 
carmobola fibre. (Hsu et al., 2008) 
1.9 Objectives 
Higher Basidiomycetes mushroom polysaccharides have been identified as 
a source of medicinal substances that express promising antitumor, immune 
modulating, cardiovascular and antihypercholesterolemia, antiviral, antibacterial, 
antiparasitic, hepatoprotective and antidiabetic effects. It is well known that water 
extracts from fruiting bodies and culture medium from higher Basidiomycetes contain 
antitumor or immunomodulating polysaccharides (Reshetnikov et al., 2001). 
Promising examples of immunoceuticals such as Lentinan, Schizophyllan, 
PSK(Krestin) are polysaccharides extracted from fruiting bodies of Lentinus edodes 
and culture medium of Schizophyllum commune and Coriolus versicolor, respectively. 
However, there are only few reports of antitumor activities of the water soluble 
polysaccharides from the sclerotia. 
The aims of the proposed research are to study the relationship between 
the chemical characteristics of these high-yielding, water-soluble polysaccharides 
isolated from mushroom sclerotia treated with micronisation and the mechanisms of 
their antitumor activity. 
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In this study, mushroom sclerotia from Pleurotus tuber-regium were first 
milled to about 0.5mm in size and then micronised into three different sizes. 
Water-soluble polysaccharides were isolated from these micronised samples by hot 
water. The chemical composition of the extracted polysaccharides including 
carbohydrate content and protein content as well as the monosaccharide profile and 
the molecular weight were determined. Finally, various cell lines were used to assess 
the in vitro and in vivo antitumor effects of these sclerotial polysaccharides. The mode 
of antitumor actions of these potential anticancer sclerotial polysaccharides were 
correlated with their chemical structure. 
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Chapter 2 Materials and methods 
2.1 Materials 
2.1.1 Mushroom sclerotia 
Sclerotia of Pleurotus tuber-regium (Fries) Singer (Figure 2.1) were supplied by 
the Sanming Mycological Institute in Fujian, China. The sclerotia were peeled and 
milled into powder by a hammer mill (IKA, MKIO) through a 0.5 mm sieve (Figure 
2.2). 
Figure 2.1 The sclerotia of Pleurotus tuber-regium 
B圍 
(a) Outer part of hammer mill (b) Blades inside the hammer mill 









S Micronisation is the reduction of particle sizes to microscale. In this study, 
i . . 
I the particle size of the sclerotial powders was reduced by micronisation using a 
I 
r single- or two-stage process involving crude grinding (Rong Tsong Iron Works RT-04, 
� China) (Figure 2.5) and ball milling (PMIOO, Retsch, Germany) (Figure 2.3). The 
： particle sizes of PTR sclerotia were measured using a microscope (Motic BA 300 with 
i丨 
I Moticam 2000) with a software for particle size analysis (Motic Image Plus�Version 
I 
\ 2.0 ML〉）(Figure 2.6). 
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Figure 2.5 Crude Grinder (Rong Tsong Iron Works RT-04, China) 
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(a) Microscope (b) Software for analysis of particle size 
Figure 2.6 MicroscopeiMotic BA 300 with Moticam 2000 and Software :Motic Image 
Plus (Version 2.0 ML) 
2.1.3 Cell lines 
Suspension cell lines including human acute promyelocytic leukemia cells, 
HL-60 (CCL-240, ATCC), chronic myelogenous leukemia cells, K562 (CCL-243, 
ATCC), 
acute monocytic leukemia cells, THP-1 (TIB-202, ATCC) and murine 
sarcoma 180, S-180 (TIB-66, ATCC), were purchased from American Type Culture 
Collection and grown in tissue culture flask (Sarstedt, Cat. # 83.1810.502). 
The HL-60, K562 were grown in IMDM medium (GIBCO, Cat. # 12200-036) 
(1.5 g/L sodium bicarbonates added, pH was adjusted to 7.4). The media were 
supplemented with 1% penicillin-streptomycin (GIBCO, Cat. # P0781), 20 % and 10 
% fetal bovine serum (FBS) (GIBCO, Cat. # 26140-079), respectively. The THP-1 
were grown in RPMI-1640 medium (Sigma, Cat # R8005) (1.5 g/L sodium 
bicarbonate added, pH was adjusted to 7.4). The medium was supplemented with 
2-mercaptoethanol (GIBCO, Cat. # 21985-023) to a final concentration of 0.05mM, 
sodium pyrurate (Sigma, Cat. # S8636) to a final concentration of 1 mM, 10% fetal 
bovine serum (FBS) and 1 % penicillin-streptomycin. The S-180 were grown in 
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DMEM medium (GIBCO, Cat. # 12100-046) (1.5 g/L sodium bicarbonate added, pH 
was adjusted to 7.4). The media were supplemented with 1 % penicillin-streptomycin 
and 10 % fetal bovine serum (FBS). Subculture was done by transferring a part of the 
cells to a new tissue-culture flask with addition of fresh medium. 
Adherent cell lines including human breast adenocarcinoma cells, MCF-7 
(HTB-22, ATCC) and monkey normal kidney cells, VERO (CCL-81, ATCC) were 
grown in monolayer in 25 cm^ tissue culture flask (Sarstedt, Cat. # 83.1810.002) in 6 
mL of RPMI 1640 medium (1.5 g/L sodium bicarbonate added, pH was adjusted to 
7.4) supplemented with 10% FBS, 1 % penicillin-streptomycin. During subculture, 
the medium was first discarded and washed with phosphate buffered saline (PBS) 
(8.182 g/L of sodium chloride, 0.201 g/L of potassium chloride, 0.204 g/L of 
potassium dihydrogen phosphate and 1.150 g/L of disodium hydrogen phosphate) to 
remove traces of serum that contained trypsin inhibitor. Then, 2 mL of 
trypsin-EDTA (1.25 mL of 2% EDTA and 5 mL of 2.5 % trypsin solution made up 
with 100 mL sterile PBS) were added to detach the cells until they were well 
dispersed, followed by the addition of 5 mL of completed medium before 
centrifugation at 1000 rpm for 5 minutes. Cell pellets were resuspended in fresh 
medium and cell suspension was transferred to new culture flasks. 
All of the above cell cultures were seeded at a concentration of 1x10^ to 1x10^ 
cells/mL and incubated at 3 7 � C in a humidified atmosphere of 5 % of CO2. The 




Purified mouse anti-human monoclonal antibodies were purchased from BD 
biosciences Pharmingenand Sigma Chemical. Goat anti-mouse secondary antibody 
Table 2.1 The antibodies used in determination of expression of proteins 
Primary Brand Catalog Source Approximate Dilution 
Antibody Number molecular applied 
weight (kDa) 
Anti-Bcl-2 Cellular 2872 Rabbit 28 1:1000 
Signaling 
Technology 
Anti-Bax BD 610983 Rabbit 21 1:500 
Biosciences 
Pharmingen 
Anti-P-actin Sigma A5316 Mouse 42 1:5000 
Chemical 
2.1.5 Animal model 
Male BALB/c mice and athymic nude (BALB/c nu/nu) mice were inbred by the 
Laboratory Animal Services Center (LASEC) of the Chinese University of Hong 
Kong and only 7-8 weeks old mice were used throughout the experiments. Ten 
BALB/c mice were housed under normal laboratory conditions (21 士 2 12/12 h 
light-dark cycle) with free access to standard rodent chow and water in the same cage. 
Three athymic nude mice were kept in each filtered cage under pathogen-free 




Sclerotial powder with initial mean particle size of about 500 )im obtained by a 
hammer mill (IKA, MKIO) was subjected to micronisation to produce different 
particle size with the following treatments (Table 2.2). 
Table 2.2 Different milling conditions used in micronisation of PTR sclerotia 
Mean particle size Milling condition 
of PTR sclerotia 
200 jim Sclerotial powder was dried for 1 hour in a 6 0 � C oven 
and then crude grinded for 10 s 
60 |im Sclerotial powder was crude grinded for 10 s and 
ball-milled for 60 minutes 
10 Sclerotial powders were dried for 1 hour in a 6 0 � C 
oven and then ball milled for 50 minutes 
For each sample size analyses, 30 particles from the same sample were measured 
with the microscope (Motic BA 300 with Moticam 2000) and the software (Motic 
Image Plus�Version 2.0 ML〉）to deduce the size range of the sample. 
Ball milling (PM 100, Retsch, Germany) was done by mixing the sample and 
agate balls (3mm in diameter) in a 1:1 (v/v) ratio ( � 1 7 0 mL each) in a 500 mL agate 
grinding bowl for 5 -15 hours at a rotary speed of 400 rpm. Crude grinding (Rong 
Tsong Iron Works 4 RT-04) was performed by putting the sample (about 250 mL) into 
the crude grinder and then grinded by the sharp blade in the grinder for different 
length of time (Chau et al., 2006; Chau et al, 2007a; Chau et al., 2007b). 
3 4 
2.2.2 Hot water extraction for mushroom sclerotia 
About 20 grams of micronised mushroom sclerotium of different particle 
sizes were used for a hot water extraction at 9 5 - 1 0 0 � C for 3 hours with a 
sample-to-solvent ratio of 1:25 (w/v). After cooling down the mixture, the mixture 
was centrifuged at 9000 rpm for 45 minutes to isolate the supernatant. The whole 
extraction process was repeated twice so that three hot water-soluble extracts were 
obtained. The supematants were pooled and dialyzed using tubing with molecular 
weight cut-off 6 - 8000 until the total dissolved solute (TDS) was below 10. The crude 
hot water-soluble extracts were lyophilized by a freeze-drier for later use. The three 
hot water-soluble extracts obtained from sclerotia powder with mean particle size of 
200 |im, 60 jim, 10 jim, were designated as shown in Table 2.3. 
Table 2.3 Table showing the designation of hot water-soluble extracts from PTR 
sclerotial powder of different particle sizes 
Particle size (|im) extract extract extract 
200 200PTR-1 200PTR-2 200PTR-3 
60 60PTR-1 60PTR-2 60PTR-3 
10 lOPTR-1 lOPTR-2 lOPTR-3 
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2.2.3 Measurement of monosaccharide profile 
2.2.3.1 Acid deploymerisation 
About 15 mg of sample was hydrolysed with 0.7 mL of 12 M concentrated 
sulfuric acid at 35�C for 60 minutes with continuous stirring. The mixture was 
diluted to 2 M sulphuric acid by addition of 3.5 mL distilled water, and the mixture 
was heated in a boiling water bath for 60 minutes. The hydrolysate was cooled to 
room temperature. 
2.2.3.2 Neutral sugar derivatization 
Three milliliters of hydrolysate was transferred to a new test tube and 
internal standard allose (1 mL, 1 mg/mL; Fluka, Cat. # 05750) was added. The pH 
of the hydrolysate was adjusted to alkaline by addition of 12 M ammonia. Five 
microliters of octan-l-ol (Sigma, Cat. # 0-4500) and freshly prepared sodium boron 
hydride (0.2 mL, 200 mg/mL in 2 M ammonia; Sigma, Cat. # S-9125) were added to 
reduce the hydrolysate. The mixture was kept at 4 0 � C for 30 minutes. After that, 
0.4 mL of glacial acetic acid was added and vortex-mixed. An aliquot of the mixture 
(0.2 mL) was transferred to a new test tube. Then, 0.3 mL of 1 -methylimidazole 
(Sigma, Cat. # 336092) as catalyst and 2.0 mL of acetic anhydride was added to 
acetylate the mixture. The mixture was vortex-mixed and left at room temperature 
for 10 minutes. Five milliliters of distilled water was then added, the mixture was 
vortex-mixed and cooled under tap water to room temperature. One milliliter of 
dichloromethane was added and the mixture was vortex-mixed and stood for 10 
minutes for phase separation. After the upper phase was removed, the lower phase 
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was washed twice with 1 mL of water. The lower phase was dried with anhydrous 
sodium sulfate and then stored in a vial at - 2 0 � C before GC analysis. 
2.2.3.3 Gas chromatography (GC) 
The alditol acetates derivatives of the neutral sugars were quantified by gas 
chromatograph (Hewlett-Packard 6890, USA) using an Alltech DB-225 capillary 
column (15 m x 0.25 mm i.d., 0.25 [im film) and oven temperature program of initial 
temperature 170 followed by a temperature rise of 2 °C/min to 220 °C with a 
final hold of 10 minutes. The injector and detector were at 2 7 0 � C . The carrier gas 
was helium and detection was by flame ionization. Individual sugars were corrected 
for losses during hydrolysis and derivatization, and for the response to the flame 
ionization detector. Monosaccharide calibration was made with fucose, rhamnose, 
ribose, arabinose, xylose, mannose, galactose, glucose, glucosamine and 
galactosamine. The N-acetylglucosamine was detected as glucosamine because the 
N-acetyl group at C-2 would be deacetylated by the sulphuric acid hydrolysis (Pazur, 
1994). The values for monosaccharides were expressed as polysaccharide residues 
(anhydro-sugars) by multiplying the amounts of pentoses with a factor of 0.88, 
hexoses with a factor of 0.90 and deoxypentoses with a factor of 0.89. 
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The amount of the monosaccharides was calculated as below: 
Amount of individual Peak area monosaccharide in sample x Amount of allose (mg) 
monosaccharide (mg) Peak area aiiose in sample 
After determining the amount of different monosaccharides, their corresponding 
percentages by weight in the sample were calculated as follows. 
Monosaccharide (Rf x coefficient x dilution factor) x Amount of monosaccharide (mg) x 100% 
% by weight Sample weight (mg) 
Rf - response factor determined f rom monosacchar ide standard 
The relative amount (normalized) of monosaccharide as % of total 
monosaccharide in the sample was calculated as follows. 
% of individual monosaccharide x 100% 
Normalized monosaccharide % = 
Total % monosaccharide in the sample 
2.2.4 Total sugar content by Phenol-sulphuric acid Method 
The samples, which were hydrolysate obtained previously from acid 
depolymerisation (2.2.3.1), were diluted 50 times in 2 M concentrated sulphuric acid 
before the analysis. Then, 0.5 mL of diluted sample solution was vortex-mixed with 
0.5 mL of 5% phenol in water. After the addition of 2.5 mL of 18 M concentrated 
sulphuric acid rapidly from a glass dispenser, the mixture was vortex-mixed, and was 
allowed to stand for 30 minutes at room temperature. The amount of sugar was 
measured by reading absorbance at 490 nm (Dubois, 1956). A calibration curve was 
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prepared by using a set of glucose standard of concentrations 100 jig/mL, 50 jig/mL, 
25 i^g/mL and 12.5 |ig/mL. The formula of calculating the % total sugar was shown 
below: 
Cone, of total sugar from standard curve (|xg/mL) x 4.2mL x 50* 
o/o Total sugar = x 100% 
Sample weight (|ig) 
* A 50 times dilution was made in the above procedures 
2.2.5 Acidic sugar content by measuring uronic acid content 
The uronic acid content was determined colorimetrically according to Official 
Methods of Analysis (45.4.11) (AOAC, 1996). An aliquot of hydrolysate (0.3 mL) 
was obtained previously from the acid depolymerisation (2.2.3.1), added to a sodium 
chloride / boric acid solution (0.3 mL, dissolving 2 g sodium chloride and 3 g boric 
acid in 100 mL distilled water) and the mixture were vortex-mixed. Five milliliters 
of 18 M concentrated sulfuric acid was added to the mixture with vortex mixing. 
The mixture was kept at 70 °C for 40 minutes. After cooling the mixture to room 
temperature, dimethylphenol [0.2 mL, dissolving 0.1 g 3,5-dimethylphenol (TCI, 
Tokyo, Cat. # D0778) in 100 mL glacial acetic acid] was added. The mixture was 
vortex-mixed and stood at room temperature for 10 minutes. Next, 2 M sulphuric 
acid was used as blank and glucuronic acid standards of concentrations 10 |ig/mL, 50 
jig/mL, 100 i^g/mL, 200 |ig/mL and 500 |ig/mL were prepared and treated similarly as 
samples. Absorbance of the sample solutions at 400 nm and 450 nm against the 
blank were measured. The reading at 400 nm was subtracted from 450 nm to correct 
for the interference from hexoses. The uronic acid content was calculated using 
D-galacturonic acid monohydrate as the standard ad expressed as a polysaccharide 
3 9 
residue by multiplying a factor of 0.89 (Scott, 1979). The formula of calculating the 
% acidic sugar was shown below: 
Cone, of acidic sugar from standard curve (|ig/mL) x 4.2mL* 
o/o Acidic sugar = x 100% 
Sample weight (|ag) 
*This was the final total volume of the reaction mixture 
2.2.6 Protein content by Lowry-Folin Method 
Lowry reagent solution (Sigma, Cat. # L3540) and Folin & Ciocalteu,s Phenol 
Reagent Working Solution (Sigma, Cat. # P5656) were prepared according to the 
instructions in the manual. The Lowry-Folin method (Lowry et al., 1951) was used to 
determine the protein content. 
Protein standard solutions with different concentrations, ranging from 25 to 200 
|ig/mL were prepared by adding distilled water to protein standard to a final volume 
of 1.0 mL. Sample solution was added to test tube and diluted 5 times to 1.0 mL 
with water. One milliliter of Lowry reagent solution was added to all standard, 
sample and blank tubes and mixed well. After that, the solutions were allowed to 
stand for 20 minutes at room temperature. Then, 0.5 mL of Folin & Ciocalteu's 
Phenol Reagent Working Solution was added to each tube with rapid and immediate 
mixing allowed color development for 30 minutes. Solutions were transferred to 
cuvettes and absorbance was measured at 750 nm against blank. Calibration curve 
was set according to protein standard solutions and original protein content of each 
sample was determined correspondingly from the curve and by multiplying an 
appropriate dilution factor. 
4 0 
Cone, of protein from standard curve (ng/mL) x 1 m L x 5* 
% Protein = — x 100% 
Sample weight (|xg) 
*A 5 times dilution was made in the above procedures 
2.2.7 Size exclusion chromatography by high pressure liquid chromatograhy 
(HPLC) 
The molecular weight of the PTR extracts were estimated by high pressure 
chromatography (HPLC) (Waters 600E, Waters). Size exclusion columns TSK gel 
G5000 PW (30 cm x 7.5 mm i.d., Supelco, Cat. # 8-05764) and G6000 PW (30 cm x 
7.5 mm i.d., Supelco, Cat. # 8-05765) with PWH Guard column (7.5 cm x 7.5 mm i.d., 
Supelco, Cat. # 8-06762) were used for determine the molecular weight profile of 
mushroom extracts according to the profile given by a range of pullulan standards 
(Shodex Standard P-82, Showa Denko). The solvents used was ultra pure water and 
the flow rate was set at 0.5 mL/min and 3.0 mL/min. Temperature of the column 
was controlled externally at 30�C and each sample or standard was allowed to run for 
30 minutes. Signals from each sample or standard were detected by refractive index 
(RI) detector. A calculation curve was obtained from the retention time of pullulan 
standards against the log value of their sizes. Molecular weight of PTR extracts was 
calculated by reference to the calculation curve. 
2.2.8 In vitro antitumor assay 
For suspension cells, 100 jiL of 2.5x10^ cells/mL with sample in medium 
(IMDM for HL-60 cells and K562; RPMI-1640 for THP-1 cells; DMEM for SI80 
cells) were added to round-bottomed 96-well plate (Sarstedt, Cat. # 83.1835.500); 
while for adhesive cells, 100 |aL of 2.5x10^ cells/mL were seeded on flat-bottomed 
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96-well plate (Sarstedt, Cat. # 83.1835) 24 hours before the addition of control and 
samples in medium (RPMI 1640 for MCF-7 and VERO cells) to be tested. Six 
concentrations of mushroom polysaccharides varied from 12.5 jig/mL to 400 |ig/mL 
were set with medium as control, trypan blue exclusion assay and MTT assay was 
used for testing the cell viability for suspension cells and adhesive cells, respectively. 
2.2.8.1 Trypan blue exclusion assay 
Different concentrations (12.5 jig/mL to 400 j^g/mL) of mushroom 
polysaccharides were added to the cell suspensions and mixed with equal volume of 
trypan blue dye (0.4% in PBS; BDH Chemicals Ltd., England, Cat. # 34078), i.e. 0.1 
mL of cell was mixed with 0.1 mL of dye and 10 j^ L of these stained cells was drawn 
onto the hemocytometer. The living cells, not being stained, of each fraction were 
counted (sample cell number) and compared with the control cell number to calculate 
the inhibition ratio by the formula below: 
(Control cell number - Sample cell number) 
Inhibition ratio (%) = x 100% 
Control cell number 
2.2.8.2 MTT Assay 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, MTT (Sigma, 
Cat. # M5655) assay (Mosmann, 1983) was carried out to assess the viability of 
adhesive cells. At the termination of the experiments (72 hours later), MTT (50 
jig/100 pL sample) were added to the wells and incubated for 5 hours at 37 °C. 
After aspirating MTT solution, the blue formazan reaction product was extracted with 
150 |iL isopropanol and was mixed well with a multi-channel pipette. Then, the 
absorbance was measured at a wavelength of 570 run. The density of living cells of 
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each fraction were compared with the control to calculate the inhibition ratio by the 
formula below: 
(Control absorbance - Sample absorbance) 
Inhibition ratio (%) x 100% 
Control absorbance 
2.2.9 Cell cycle analysis by Flow Cytometry 
Cells were placed on 6-well tissue culture plate (Sarstedt, Cat. # 83.1839) at a 
density of 2 x 10^ cells/mL in order to allow triplicate measurements for both control 
and treatment group. Different amount of culture medium (IMDM for HL-60 cells 
and RPMI-1640 for THP-1 cells) was added to a final volume suitable for growing 
cells for 24, 48 and 72 hours. Then, different amount of extract dissolved in culture 
medium was added accordingly in order to find out the effective concentration for 
reducing about 50 % growth of cells. This concentration was determined by adding 
six concentrations of samples to cells from 12.5 jig/mL to 400 jig/mL for in vitro 
assay so that a particular concentration of sample was responsible for growth 
inhibition of cells by about 50 %. After 24, 48 or 72 hours, cells were harvested by 
transferring them to polystyrene tubes and centrifuged at 2000 rpm for 5 minutes. 
Cell pellets were collected with the removal of culture medium and were washed 
twice with 2 mL of IX PBS at 2000 rpm for 5 minutes. Following to the removal of 
last drip of PBS, 2 mL of ice cold 70 % ethanol was added to resuspend the cell pellet 
for fixation. The cell suspension was kept at - 2 0 � C until staining. 
Cell suspension was first spinned down at 2000 rpm for 5 minutes to remove 
ethanol. Cells were washed twice again with 2 mL of IX PBS at 2000 rpm for 5 
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minutes. One milliliter of propidium iodide (PI) [L21g/L of Tris, 0.05g/L of PI 
(Sigma, Cat. # P4170)] adjusted to pH 8.0 and O.OOlg/dL of RNase A (Sigma, Cat. # 
R4875)] was then added to resuspend cell pellet subsequent to the removal of last 
drop of PBS. The Pl-stained cell suspension was transferred to a tube specifically 
for flow cytometry by passing through 40|am nylon mesh beforehand to prevent 
formation of clumps. The tube containing filtered cells was kept at 4 °C before 
carrying out flow cytometry analysis (Loken and Stall, 1982). Cells were analyzed 
for DNA content using flow cytometer (Beckman Coulter, XL-MCL, USA). The 
distribution of cells in sub-Gi, Gi, S and G2-M was determined using MultiCycle 
Analysis AV software (Phoenix Flow Systems, San Diego, CA). The sub Gi peak was 
regarded as an indicator of the onset of apoptosis. 
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2.2.10 Protein expression involved in apoptosis and cell-cycle 
The protein expression in the cells treated with PTR sclerotia extract is 
determined by Western blot. After treated with sample, cells were collected and lysed 
to isolate protein. The protein content in the cell lysates obtained were quantified first 
before separation of protein by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE). The protein of interest was detected by western blot 
(Mini-PROTEAN 3 Electrophoresis System; Bio-Rad Laboratories). 
2.2.10.1 Cell lysates preparation 
Cells at a density of 2x10^ cells/mL were placed on 6-well tissue culture plate 
(Sarstedt, Cat. # 83.1839), three wells each for control and treatment group, and were 
co-incubated with the PTR extracts at the same concentration used in flow cytometry 
for 24, 48 and 72 hours. The cells from the three wells were pooled and were 
centrifuged at 2000rpm for 5 minutes and the cell pellet was washed with PBS twice. 
The cell pellet was then lysed by 0.1 - 0.2 mL of ice-cold lysis buffer containing 2 jiL 
of protease inhibitor cocktail (BD Biosciences Pharmingen, Cat. # 554779) for one 
hour on ice with occasional vortexing. The cell lysate was then transferred to a 1.5 mL 
microtube and centrifuged at 14,000 rpm for 15 minutes. The supernatant was 
transferred to a new microtube and was kept at -20 before determination of protein 
concentration. 
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2.2.10.2 Determination of protein concentrations 
The protein concentration of the cell lysate is determined by BCA protein assay. 
The coloured complex formed is proportional to the amount of protein in the cell 
lysate and was determined by the measurement of absorbance at 562 nm. The protein 
content was quantified using a calibration curve obtained from a set of BSA protein 
standards. (25, 50, 100, 200, 400 and 800 jig/mL). The sample was diluted 50 times 
by distilled water. 200 ^L of working reagent from the BCA protein assay kit was 
added (50 parts of reagent A was vortex-mixed with one part of reagent B) into 25 jjL 
of diluted sample and BSA protein standards in a microplate. The microplate was 
incubated at 37 for 30 minutes and the absorbance was measured by the microplate 
reader (SpectraMAX 250, Gene Co. Ltd) at 562 nm. The protein concentration of cell 
lysates was calculated as follows: 
Actual protein concentration (|ig/jiL) in sample 
=Protein concentration (jig/mL) derived from the standard curve x 50* x 1000** 
* dilution factor 
** conversion factor 
2.2.10.3 Western blot 
Thirty to sixty micrograms of protein from cell lysate was required. Cell lysate 
were diluted with 2X loading dye to obtain desired protein amount. The sample was 
heated for 5 minutes at 95 in a Thermomixer comfort (Eppendorf, company) 
before loading. 
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The proteins in the cell lysate were packed on 5 % stacking gel and 
electrophoresed on 12 % SDS separating gel. The two glass plates were washed with 
distilled water and 70 % ethanol subsequently. The glass plates were held by the 
casting frame. Around 5mL of 12 % SDS separating gel was first added in between 
the two plates. Bubbles inside the glass plates were removed by gently knocking the 
glass plate. The gel was covered and flattened by isopropanol. After 60 minutes for 
gel polymerisation, isopropanol was poured off and distilled water was added in for 
washing. The last bit of distilled water was removed and absorbed by filter paper. 
Then 5 % stacking gel was added on the top of the separating gel and the comb was 
inserted. The gel was allowed to stand for 15 minutes for gel polymerisation. 
After the gel was polymerised, the comb was removed and the glass plates were 
put into the tank for western blotting. The centre between the two glass plates was 
filled with IX cathode running buffer (14.4 g glycine, 3.03 g Tris-base and 1 g SDS 
dissolved in 1 L of distilled water) to ensure the wells were covered by it. The outer 
part of the tank was filled with IX anode running buffer (14.4 g glycine and 3.03 g 
Tris-base dissolved in 1 L of distilled water). Ten microliters of Precision Plus Protein 
dual color standards (Bio-Rad Laboratories, Cat. # 161-0374), 10 fxL of Biotinylated 
Protein Ladder (Cell Signaling Technology, Cat. # 7727) and 20 \iL of sample were 
loaded into the wells using fine-tipped pipettes. The standard marker and the sample 
were migrated on the stacking gel at 90 V and were separated on the separating gel at 
110 V until the end-point of the electrophoresis which was determined by the 
pre-stained protein standard marker. 
The separated proteins on the polyacrylamide gel were transferred to the 
Trans-Blot® Transfer Medium Pure Nitrocellulose Membrane, 0.2 jj,m for protein 
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blotting (Bio-Rad Laboratories, Cat. # 162-0112). The membrane, sponges, filter 
papers were first pre-wetted by IX transfer buffer (14.4 g glycine and 3.03 g Tris-base 
were dissolved in 800mL of distilled water, followed by an addition of 200 mL of 
methanol). The membrane sandwich was assembled based on the kit instructions with 
the following sequence from the negative side to the positive side: sponge, filter paper, 
gel, membrane, filter paper, and then sponge. Bubbles were squeezed out from the 
membrane sandwich with the help of a flow tube. After placing it and the ice block 
into the transfer tank, it was fully filled with IX transfer buffer. The transfer process 
was carried out at 100 V for one hour. After transfer process, the membrane was first 
washed with IX TBS (24.2 g Tris-base and 80 g NaCl were dissolved in 1 L of 
distilled water, pH adjusted to 7.6), and then shaken in the freshly-prepared blocking 
buffer (5 g Milk powder and 0.1 mL Tween 20 dissolved in 1 L IX TBS) for one hour. 
After blocking, the membrane was kept in a plastic box, probing with 3 mL of 
the corresponding primary antibody which was diluted by blocking buffer according 
to the recommendation (Table 2.1). The plastic box with the membrane was shaken on 
an orbital shaker at 4 overnight. The membrane was then washed 3 times by TTBS 
(24.2 g Tris-base, 80 g NaCl and 1 mL Tween 20 dissolved in 1 L of distilled water, 
pH adjusted to 7.6) on an orbital shaker at a 5-minute time interval. After that, the 
membrane was probed with 3 mL of the goat anti-mouse secondary antibody 
conjugated to horseradish peroxidase (HRP) or goat ant-mouse secondary antibody 
conjugated to horseradish peroxidase (HRP) which was diluted by the blocking buffer 
or BSA for an hour at room temperature. After washing the membrane 3 times with 
TTBS at a 5-minute time interval, it was kept in the TTBS until the detection process 
was performed. 
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The protein of interest was visualized by the chemiluminent protein detection 
system. One milliliter of detection substrate buffer from the Phototope®-HRP Western 
Blot Detection System, Anti-rabbit IgG, HRP-linked Antibody (Cell Signaling 
Technology, Cat. # 7071) was added on the membrane for 5 minutes. Finally, in the 
dark room, the membrane was covered by an X-ray film in a film cassette with an 
optimal time and the film was developed by the X-ray film processor (Kodak). 
The western blot was scanned and quantified with the software LumiAnalysis 3.1 
of Lumi-Imager (Roche Molecular Biochemicals). The intergrated values for each 
band were taken and their ratios against P-actin were calculated. 
Intergrated value of band for sample 
Relative quantity of the band for sample = 
Intergrated value of band for P-actin 
Normal ized band value Relative quantity of the band for sample 
= X 100% 
for sample (%) Relative quantity of the control band 
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2.2.11 In vivo antitumor assay 
2.2.11.1 BALB/c mice 
On day zero, 7-8 weeks old male BALB/c mice were weighed and were then 
placed in the animal house. After that, 0.2 mL of 5 x 10^ cells of the solid tumor — 
Sarcoma S-180 was implanted at the back of each mouse. For the subsequent 10 
days (day 1 to day 10), 0.2 mL of mushroom extracts of 20 mg/kg of body weight or 
PBS as the control were injected into the peritoneal cavity of the mice (10 mice per 
group). On day 11, the mice were terminated and the tumors at the back were cut off 
for weighing. The weight of the tumors from each group was averaged and 
compared with that of the control group to calculate for the inhibition ratio as below: 
(Control tumor weight 一 Sample treatment tumor weight) 
Inhibit ion ratio (%) = x 100% 
Control tumor weight 
2.2.11.2 Athymic nude mice 
At the beginning of experiment, 7-8 weeks old male nude mice were weighed. 
The human tumor xenograft where HL-60 was resuspended in BD® Matrigel (BD, 
Cat. # 356237) (5x10^ cells per 0.2 mL for each mouse) and was implanted 
subcutaneously at the back of the athymic nude mice. The tumors were allowed to 
grow for about 21 days until reaching the volume of 50-100 n W in which the tumors 
were measured periodically using a veniper caliper and the volume of the tumors was 
calculated using the formula: Volume = (Weight^ x Length)/2, where this volume was 
considered to be a valid estimation of tumor weight with the assumption of uniform 
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density. The tumor-bearing mice were randomly separated into groups of seven 
(mean tumor size distribution are the same in each group) prior to intraperitoneal 
injection of 0.2 mL (10 mg/kg of body weight) of corresponding mushroom extracts 
or PBS as control for 10 consecutive days. 
The mice were sacrificed at day 11 by cervical dislocation and tumors were 
excised from the back, measured by caliper and weighed. The volume and weight of 
the tumors from each group were measured, averaged and compared with that of the 
control group to calculate for the inhibition ratio as below: 
(Control tumor volume or weight - Sample treatment tumor 
Inhibit ion ratio (o/o) = volume or weight) x 100% 
Control tumor volume or weight 
2.2.12 Statistical methods 
All analyses were performed in triplicate. The data were recorded as mean 士 
standard deviations and analyzed by SPSS (Version 11.0 for Windows 98, SPSS Inc.). 
Difference between two groups was analysed by two-tailed Student's t-test, and 
difference between three or mor groups was analysed by one-way ANOVA followed 
by multiple comparisons. Differences with p < 0.05 level were considered to be 
significant. 
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Chapter 3 Results and Discussion 
3.1 Yield of hot water-soluble extracts from Pleurotus tuber-regium 
Hot water was selected as a medium of extraction for polysaccharides from 
Pleurotus tuber-regium. The total yield of extracts was found to be 6.80 %, 11.6 % 
and 36.1 % for 200PTR, 60PTR and lOPTR, respectively. The yield of each fraction 
from the micronized PTR scleroita was shown in Table 3.1. 
The mushroom sclerotia of different particle sizes were treated by three 
successive hot water extractions. The highest yield of hot water-soluble extracts 
extracted was obtained from the first extraction which was also the fraction with the 
highest water solubility. This trend is similar to a study of which the yield of three 
fractions obtained by hot water extraction from the fruiting body of Agaricus blazei 
was 3.2 o/o, 0.5 % and 0.4 % according to the sequence of extraction (Ohno et al., 
2001). 
The yield of water extracts for mushroom polysaccharides by water extraction is 
usually low (less than 10 %). For example, the yield of lentinan from Lentinus edodes 
was only 0.16 % by water extraction (Chihara et al., 1970) and the collective yield 
from fruiting body of Agaricus blazei was 4.1 % only (Ohno et al., 2001). For the hot 
water extract of unmicronised PTR sclerotia powder (500PTR), the total yield of three 
successive extracts obtained was 3.6 % according to the previous studies (Lai, 2005). 
Comparing with these examples，reduction of particle size by micronisation seemed to 
be an effective treatment to extract water-soluble mushroom polysaccharides 
especially from mushroom sclerotial powder. 
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Among mushroom sclerotia with mean particle size ranging from 10-200 jim, the 
yield of hot water-soluble extracts extracted increased with a decrease in the particle 
size of mushroom sclerotia. It is proposed that reduction of particle size of sclerotia 
can increase the surface area and hence the yield of polysaccharides extracted. 
To extract mushroom polysaccharides, the cell wall structure has to be broken 
down to release the polysaccharides which are the structural component. The 
extraction can be done by using different solvents and under different conditions (e.g. 
hot water at various temperature, hot alkali, cold alkali and sonication). Among which 
the most popular and simplest way of extraction is by hot water. Well-known 
antitumor native mushroom polysaccharides like PSK and Lentinan are hot water 
extracts from Coriolus versicolor and Lentinus edodes, respectively. 
Hot water was also chosen to be the extraction medium in this study because hot 
water is a traditional method to extract bioactive substances from mushrooms which 
had potent activity against various kinds of disease (Mizuno, 1999), particularly 
strong antitumor activities (Chihara, 1969; Ikekawa, 1968, 1969). A previous study 
also found that hot water treatment is a better method than ultrasonic one to obtain 
polysaccharides from PTR mycelium and sclerotia which have high antitumor 
activities that is host-mediated and cytocidal (Zhang et al., 2004b). 
The medium of extraction also affects the solubility of the polysaccharides. It 
was reported that sonication was less effective in extracting soluble materials from 
Pleurotus tub er-re gium than from Poria cocos and Polyporus rhinocerus (Lai, 2005). 
Also, hot water extracts would not cause problems like hepatoplenomegaly (Riggi and 
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Di Luzio, 1962), granuloma formation (Williams et al., 1985), microembolization and 
enhanced endotoxin sensitivity (Browder et a/., 1987) which therefore facilitates their 
medicinal and clinical applications (Zhang et al., 2004b). 
Extraction also has an effect on the molecular weight and conformation of the 
polysaccharides obtained and hence the structure-activity relationship. Treatments like 
high temperature, ultrasonic energy and alkaline might influence the conformation of 
(l-^3)-p-D-glucan (Yadomae and Ohno, 1996). Basically, the (1^3)-P-D-glucan has 
three types of conformation namely, random coil, single helix and triple helix. The 
change of conformation can be achieved by chemical and physical treatments. For 
example, alkali treatment will render the glucan to become random coil (Ogawa et al.， 
1972). After neutralization, dilution or dialysis, it will resume to helical structure 
(Yadomae and Ohno, 1996). 
Glucan exists as a random coil under higher temperature but change to a single 
helical conformation upon lowering of temperature, some may even form triple helix 
as a more stable conformation (Yadomae and Ohno, 1996). In this study, hot water at 
95 was chosen as extraction medium. After extraction the mushroom solutions 
were allowed to cool and dialysis for the crude extract. The hot water extracts of PTR 
sclerotia were presumably to have single helical conformation as the lowering of 
temperature usually leads to single helix formation. 
The temperature used for extraction in this study was 95 Although an 
increase in the extraction tempertaure can enhance solubility of polysaccharides in 
aqueous solutions and hence the yield, only 95 was applied because excessive heat 
will reduce molecular weight of polysaccharides and disrupt the conformation that 
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could not be regained after cooling (Hobbs, 2005). For example, the triple helix 
structure of Schizophyllan was lost after heating at above 1 3 5 � � ( B r a n t et al., 1997). 
Table 3.1 Yield of various hot water-soluble extracts of Pleurotus tuber- regium sclerotia 
Sclerotia Fractions Yield % dry weight Total yield % 
*500PTR / / 3.60 
1 3.60 
200PTR 2 1.75 6.80 
3 1.45 
1 4.10 
60PTR 2 3.55 11.6 
3 3.90 
1 25.1 
lOPTR 2 7.35 36.1 
3 3.64 
*Data of mushroom sclerotial powder of 500 |im particle size were obtained 
from Lai, 2005 
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3.2 Chemical composition of hot water-soluble extracts from PTR 
3.2.1 Total carbohydrate content 
The total carbohydrate content was determined by the phenol-sulphuric acid 
assay using glucose as calibration standard. The carbohydrate content of the hot 
water-soluble extracts of micronised PTR sclerotia varied largely from 50.76 % to 
87.37 o/o (Table 3.3). 
For each sample, the carbohydrate content of the first fraction was the lowest 
among the three fractions. As the extraction process was repeated, high temperature 
was reapplied to the mushroom and more cell wall breakdown was expected. 
Therefore, more carbohydrate-rich polysaccharides were obtained. 
The average carbohydrate content of 200PTR, 60PTR, lOPTR are 60.1 %, 73.9 
%, and 80.9 %, respectively (Table 3.2). When comparing with the unmicronised PTR 
sclerotia extract (500PTR) which had a carbohydrate content of 34.9 %, the 
micronised samples had average carbohydrate content of more than 50 % which 
means carbohydrate was the dominant component in the extracts. This indicated that 
micronisation / size reduction of PTR mushroom sclerotia is effective in extracting 
carbohydrate-rich substances from PTR sclerotia. 
Besides, when the particle size of the sclerotial powder was reduced from 200 
jim to 10 the carbohydrate content in the extracts increased. The highest 
carbohydrate content 87.73 % was observed in lOPTR-2. On the other hand, the 
lowest carbohydrate content 50.76 % was found in 200PTR-1, indicating the 
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co-existence of other non-carbohydrate substances. Interestingly, the effect of 
micronisation on the trend of carbohydrate content on PTR sclerotia extract matched 
with that of the extraction yield. Even the crude extract of unmicronised sclerotia 
(500PTR) which has average particle size of 500 |im matched with the trend. The 
extraction yield and carbohydrate content increased in the order lOPTR > 60PTR > 
200PTR > 500PTR (Table 3.2). To summarize, reduction of particle size by 
micronisation from 500 [im to lOum is effective to obtain carbohydrate-rich hot 
water-soluble extracts from PTR sclerotia by hot water extraction. 
Mushroom polysaccharides are cell wall structural constituents. The cell wall has 
to be broken down to release the polysaccharides. During size reduction of sclerotial 
powder, the cell wall material was subjected to disintegration. Smaller particles are 
obtained from more vigorous micronising condition and hence the degree of cell wall 
rupture will be much higher. The polysaccharides, being the cell wall component, 
will be more susceptible for extractioin and hence resulting in a an extract with higher 
yield and carbohydrate content. 
3.2.2 Uronic acid content 
Glucuronic acid and galacturonic acid are major acidic monosaccharides in 
mushroom polysaccharides. The content of acidic sugar in PTR sclerotia was 
determined by the uronic acid method as total amount of uronic acids. 
In general all the fractions consisted of very low uronic acid (less than 4%), 
ranging from 1.10 % to 3.99 % (Table 3.3). The mean uronic acid content for 200PTR, 
60PTR, lOPTR is 1.93 %, 1.72 % and 3.55 %, respectively (Table 3.2). The result 
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agreed with previous findings that mushroom polysaccharides usually have low acidic 
sugar. For example the unmicronised PTR sclerotia (500PTR) has extremely low 
uronic acid content of 0.47 %. 
3.2.3 Protein content 
The soluble protein content was determined by the Lowry-Folin method using 
BSA as protein standard to construct a calibration curve. The soluble protein content 
varied greatly from 9.24 % to 50.7 % (Table 3.3). 
The average protein content of 200PTR, 60PTR, lOPTR is 39.0 %, 25.7 % and 
10.7 o/o, respectively (Table 3.2). Their protein content was relatively lower (less than 
50 %) than unmicronised 500PTR which was found to have protein as a dominant 
constituent (66.6 %). 
Besides, the protein content decreased as the particle size decreased from 500 [im 
to 10 j^m. This trend was also found to be complementary to that of carbohydrate 
content. To produce sclerotial powder of smaller particle size, more vigorous 
micronising condition was expected and degradation of protein might be resulted. 
Since Lowry-Folin method is a colorimetric method which is based on the formation 
of copper ion complex with amide bonds and reduction of Folin-Ciocalteu reagent 
(phosphomolybdate and phosphotungstate) by tyrosine and tryptophan residues 
(Lowry et al., 1951), degraded protein will not be able to be detected. Also, as the 
sclerotial particle size decreased, the extraction yield increased resulted in extracts 
with a decreased protein content. As shown in Table 3.1 and 3.3, the extract with the 
highest yield of 25.1 % was lOPTR-1, which also had the lowest protein content of 
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9.24 %. On the other hand, the extract with the lowest yield of 1.45 % was 200PTR-3, 
which also had the highest protein content of 50.7 %. This might be due to the fact 
that the fixed amount of protein in the PTR sclerotial powder was distributed in a 
larger amount of extract, resulting in a lower percentage of protein content in the 
extracts that had a higher yield. 
In summary, micronisation is an effective prior treatment before extraction to 
obtain extract carbohydrate-rich mushroom polysaccharides, and cause a shift of 
dominant constituent from protein to carbohydrate in the extract. 
An extract from the fruiting body of Lentinus edodes was identified as 
(l+3)-P-D-glucan and was found to possess potent in vitro and in vivo antitumor 
effect against Sacroma 180. However, the antitumor acitivity was much lower when 
the bound protein of the extract was removed by acetone treatment. This study 
illustrated the importance of bound protein on the antitumor activity (Surenjav et al” 
2006). 
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Table 3.2 Averaged chemical composition of hot water-soluble extracts 
of PTR sclerotia (%) 
Sclerotia % Total Carbohydrate % Uronic acid %Protein 
*500PTR 34.89 0.47 66.6 
**200PTR 60.1 ± 11.2' 1.93 ± 0.755a 39^ ± 13.6' 
**60PTR 73.9 士 9.93ab 1.75 士 0.481" 25.7 士 3.98b 
**10PTR 80.9 士 l O j b 3.55 士 0.637b IQ.T 士 1.68" 
*Data of mushroom sclerotial powder of 500 jim particle size were obtained 
from Lai, 2005 
**Data are average of hot water-soluble extracts from three successive extractions 
Data are means 士 S.D. (n=6); different superscript represent significant difference in 
the same column (ANOVA，multiple comparison, p <0.05) 
Table 3.3 Chemical composition of hot water-soluble extracts of 200PTR, 
60PTR and lOPTR (%) 
Sclerotia Fractions % Total Carbohydrate % Uronic acid %Protein 
200PTR 1 50.8 ± 12.5a 1.10 ±0.0501" 45.3 ±1.17" 
2 71.5 士 3.90' 2.42 ± 0.417a 21.1 ± l.Olb 
3 58.1 ± 2.04a 2.27 ± 0.76a 50.7 士 0.781� 
60PTR 1 64.4 ± 6.48a 1.34 士 0.518' 28.7 ± 0.819a 
2 82.0 士 0.92a 1.67 士 0.438a 20.5 士 0.417b 
3 80.1 ± 5.06a 2.15 ± 0.195a 27.8 ±1.10" 
1OPTR 1 68.3 士 9.29a 2.79 ± 0.339a 9.24 士 1.22a 
2 87.4 士 3.18a 3.99 ± 0.389a 10.4 ± 0.382' 
3 87.0 士 0.60ia 3.86 ± 0.184a 12.6 士0.919" 
Data are means 士 S.D. (n=3); different superscript represent significant difference in 
the same column (ANOVA, multiple comparison, p <0.05) 
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3.3 Monosaccharide profiles of hot water-soluble extracts from PTR by gas 
chromatography (GC) 
In all extracts glucose was found to be the dominant monosaccharide. The 
glucose content accounted for more than 90% in the monosaccharide profile of all the 
extracts of the micronised samples (Table 3.5 - 3.7). In particular, 60PTR-3 had 100.0 
o/o glucose, implying that it was likely to be a pure P-glucan. In contrast, the 
unmicronised 500PTR had a much lower glucose content of 81.1 % only (Table 3.4). 
It was observed that the average amount of glucose in the extracts as particle size 
of sclerotial powder decreased in the order of lOPTR > 60PTR > 200PTR > 500PTR 
(98.4 o/o, 98.3 o/o, 94.8 % and 81.1 % respectively) (Table 3.4). This indicates that 
glucans with higher purity could be obtained effectively with reduction of particle size 
up to 10 |im. 
Mannose was the other monosaccharide present in the fractions. Considerable 
amount of mannose, ranging from 1.07 % to 8.73 % (Table 3.5 - 3.7), was present in 
most of the fractions, indicating the presence of some water-soluble mannoglucan. 
Generally, the average amount of mannose was relatively higher in larger size PTR 
sclerotial extracts with a descending order 500PTR > 200PTR > 60PTR >10PTR 
(13.9 o/o, 5.22 o/o, 1.67 % and 1.29 %, respectively) (Table 3.4). The protein content of 
these hot water-soluble extracts also followed the same trend with decreasing protein 
content as particle size decreased (Table 3.3). This may imply the presence of 
mannoprotein (Reshetnikov et al, 2001). 
Trace amount of galactose, ribose and xylose was present in the monosaccharide 
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profile of 500PTR while they were absent in the three micronised samples. This may 
due to a higher yield in smaller size sclerotial powder like lOPTR so that the amount 
of galactose, ribose and xylose become even less significant and not detected in the 
monosaccharide profile. 
Glucosamine was detected as N-acetylglucosamine from chitin in fungal cell 
wall (Michell and Surfield, 1967). Only trace amount of glucosamine was detected in 
1 OPTR-3 which consisted only 0.98 % while no glucosamine was found in other 
fractions. Also, no galactosamine was detected in any fractions indicating an absence 
of linkage between carbohydrate and protein (Biermann, 1990). 
In summary, glucose and mannose were detected as the main monosaccharide 
component in all hot water-soluble extracts of micronised PTR sclerotia but in 
different proportions with glucose being the most dominant monosaccharide. A 
reduction of average particle size of PTR sclerotial powder from 500 |im to 10 jim 
could result in hot water-soluble polysaccharides with a more homogeneous 
composition of higher percentage of glucose. 
Table 3.4 Normalized % of monosaccharide of 500PTR, 200PTR, 60PTR and lOPTR 
*500PTR 林200PTR **60PTR **10PTR 
Ribose 0.79 0.00 0.00. 0.00 
Xylose 0.58 0.00 0.00 0.00 
Mannose 13.9 5.22 1.67 1.29 
Galactose 3.64 0.00 0.00 0.00 
Glucose 81.1 94.8 98.3 98.4 
Glucosamine ^ ^ ^ 0.33 
*Data of mushroom sclerotial powder of 500 jim particle size were obtained 
from Lai, 2005 
**Data are average of hot water-soluble extracts from three successive extraction 
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Table 3.5 Monosaccharide profile (normalized %) of various hot water-soluble 
extracts of200PTR 
2QQPTR-1 2QQPTR-2 2Q0PTR-3 
Mannose 8.73 士 0.327" 1.07±0.169b 5 .86±1.36 ' 
Glucose 91.3 ±5 .26 ' 98.9 ± 7.09b 94.1 士 9.20� 
Data are means 士 S.D. (n=2); no significant difference in the same row 
(ANOVA, multiple comparison,<0.05) 
Table 3.6 Monosaccharide profile (normalized %) of various hot water-soluble 
extracts of 60PTR 
60PTR-1 60PTR-2 60PTR-3 
Mannose 3.74士 0.374a 1.25 ± 0.095iab 
Glucose 96.3 士 98.7 士 0.485ab lOO'' 
Data are means 士 S.D. (n=2); no significant difference in the same row 
(ANOVA, multiple comparison, p <0.05) 
Table 3.7 Monosaccharide profile (normalized %) of various hot water-soluble 
extracts of lOPTR 
lQPTR-1 lOPTR-2 lQPTR-3 
Mannose 1.14^0.121" 1.20 ± 0.0492a 1.52 ± 0.125a 
Glucose 98.9 ± 1.55' 98.8 ± 0.769' 97.5 ± 6.03' 
Glucosamine 0.98 ± 0.20 
Data are means 士 S.D. (n=2); different superscript represent significant difference in 
the same column (ANOVA, multiple comparison, p <0.05) 
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3.4 Molecular weight profile of hot water-soluble extracts from PTR by size 
exclusion chromatography (SEC) 
HPLC is a separation technique by which compounds in a mixture are separated 
on a stationary phase. The mobile phase (eluant) which carries the sample and the 
stationary phase is liquid. HPLC separates a mixture based on the different 
compatibility of sample components for the eluant and stationary phase. To 
manipulate the separation, a change of the concentration and composition of the 
eluant is needed (Brummer and Cui, 2005). 
Size exclusion chromatography (SEC) is a chromatographic technique by which 
molecules in a mixture are separated based on their size. It is widely used as to 
separate and characterize mixtures of oligosaccharides based on size. Molecules in a 
eluant buffer are directed into a column filled with a gel packing of clearly defined 
pore size. Smaller molecules in the samples will be hold up in the column and take 
longer time to be eluted out than the larger molecules. The elution time is inversely 
correlated to the molecular weight of the sample. Eluent from the column is 
monitored using one or more detectors. Usually refractive index detectors are used 
alone or in combination with light scattering and viscosmetric detectors (Brummer 
and Cui, 2005). 
TSK-Gel PW columns are used in this study to separate the molecules in the 
crude extract of micronised PTR sclerotia based on size. The column is made up with 
hydrophilic polymer matrix andhas excellent chemical and mechanical stability. It is 
commonly used with aqueous solvents, the polymer matrix is compatible with up to 
50% organic solvent. PW-type resin is less hydrophilic than polysaccharide gels and it 
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has a small residual negative charge. Sometimes, addition of organic modifier or a 
decrease in salt concentration is needed to reduce hydrophobic interactions (Supelco, 
2000) 
Eight pullan standards were used for constructing the calibration curve needed 
for determining the molecular weight of the crude extracts. This set of standards is 
either a pullulan or polymaltotriose that is a linear polysaccharide consisting of 
maltotriose ranging from 0.59 x lO* Da (P5), 1.18 x lO"^  Da (PIO), 2.28 x lO"^  Da 
(P20), 4.73 X 104 Da (P50), 11.2 x 10^ Da (PI00), 21.2 x 10^ Da (P200), 40.4 x 10^ Da 
(P400) and 78.8 x lO"^  Da (P800). These standards were used to make up of a 
calibration curve for the two size exclusion columns - TSK G6000 and TSK G5000 
[Figure 3.1 and 3.3] so that molecular weight of extracts was determined accordingly. 
Ultrapure water was used as the dissolving and eluting solvent in this study as 
the hot water extracts were preferentially soluble in ultrapure water. Other solvent like 
NaCl solution is also widely used since it can give an ionic strength that prevent 
aggregation of the extracts and provided good resolution. TSK Gel G6000 PW and 
G5000 PW rather than columns like G3000PW were used since a column with a 
larger pore size will give better resolution in spreading out peaks of fractions with 
generally large moleculer weight. 
There was only one peak appeared in the SEC profile of the three hot 
water-soluble extracts of lOPTR [Figure 3.2 (a), (b) and (c)]. The average molecular 
weight of the peak was larger than the largest pullulan standard (P800) which implied 
that the molecules in lOPTR-1, lOPTR-2 and lOPTR-3 were larger than 78.8 x Da, 
Also, only one peak was detected in the three extracts from lOPTR , indicating that 
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the composition of the three fractions was rather homogenous. 
For the two extracts of 200PTR, three peaks were observed [Figure 3.4 (a) and 
(b)]. For 200PTR-1, the average molecular weights of the first, second and third peak 
are > 78.8 x 10^ Da, 24.0 x lO* Da and 7.80 x 10^ Da, respectively. For 200PTR-2, the 
average molecular weights of the first, second and third peak are > 78.8 x lO^ Da, 37.6 
X 104 Da and 9.23 x Da, respectively. It is not surprising that more than one 
fraction was found in 200PTR since they were crude water extracts only. 
High molecular weight glucans of mushroom polysaccharides are generally 
considered to be more effective than those of low molecular weight (Wasser, 2002; 
Mizuno et al, 1996). For example, well-known examples like Lentinan and 
Schizophllan had a MW of 50 x lO* Da and 45 x lO* Da, respectively (Mizuno et al., 
1995). Thus, lOPTR-1, lOPTR-2, lOPTR-3, 200PTR-1 and 200PTR-2, which were 
found to have a high molecular weight fraction > 78.8 x lO"^  Da, were considered to be 
potential antiproliferative polysaccharides. 
Other samples like fractions of 60PTR, and 200PTR-3 were not examined in this 
molecular weight determination method because of their viscous nature. Glucans of 
high molecular weight usually exists as single and/ or triple helix conformations 
(Yadomae and Ohno, 1996). Viscosity is usually high in helical conformation, making 
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Table 3.8 A summary of SEC results of the various hot water-soluble extracts of 
lOPTR showing their estimated molecular weight 
Molecular weight (Da) 
1 St peak 
lOPTR-1 >78 .8x104 
lOPTR-2 >78 .8x104 
lOPTR-3 > 78.8 X 10^ 
Table 3.9 A summary of SEC results of the two hot water-soluble extracts of 200PTR 
showing their estimated molecular weight 
Molecular weight (Da) 
1 St peak 2nd peak 3rd peak 
200PTR-1 > 78.8 x lO* 24.0 x 10^ 7.80 x lO"^  
200PTR-2 >78 .8x104 37.5 x 10^ 9.23 x 10^ 
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3.5 Antitumor effects of various hot water-soluble extracts from PTR 
3.5.1 In vitro antitumor study 
3.5.1.1 In vitro antiproliferative study by HL-60 
The first two extracts of 200PTR showed inhibitory effect against acute leukemia 
HL-60 cells. 200PTR-1 showed antiproliferative activity starting from 100 ^ig/mL. 
The antiproliferative activity was nearly 80% at 200 |ig/mL. When the concentration 
is doubled to 400 |ig/mL, the inhibitory effect could even be enhanced to about 99 %, 
indicating that 200PTR-1 was effective in inhibiting growth of HL-60 cells. 
200PTR-2 showed a weaker antiproliferative activity in which about 50 % inihibtion 
was only achieved at 400 jig/mL. However, 200PTR-3 barely had inhibition on 
HL-60 cells (Table 3.10). 
Table 3.10 Inhibition ratio (%f of hot water-soluble extracts from 200PTR on HL-60 
一 2Q0PTR-1 200PTR-2 200PTR-3 — 
400 [ig/mL 9 9 . 4 士 0 . 3 7 * * 5 4 . 3 土 2 . 5 2 * * 1 . 8 0 士 7.03 
2 0 0 |ig/mL 7 9 . 4 士 2 . 5 6 * * 2 3 . 9 ± 5 . 2 8 * * -
100 |ig/mL 21.9 士 2.96** - -
50 [ig/mL -b - 1.05 ±3.06 
25 昭/mL - - 3.49 ±4.72 
12.5 |ig/mL - - -
^Data are means 土 S.D. (n=4); means are significantly different from the control group 
(Student's t test ** for /7<0.001); means are significantly different from the control 
group (Student's t test * for /?<0.05) 
bNo inhibition observed 
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Only the first extract of 60PTR had inhibitory effect on HL-60 cells. 60PTR-1 
showed inhibition starting from 100 |ig/mL and had about 70 % antiproliferative 
effect at 400 |ig/mL. Although 60PTR-3 showed an inhibition at 100 |ig/mL, 60PTR-2 
was hardly effective in inhibiting growth of HL-60 cells (Table 3.11). 
Table 3.11 Inhibition ratio (Vof of hot water-soluble extracts from 60PTR on HL-60 
60PTR-1 60PTR-2 60PTR-3 
400 |ig/mL 77.7 ±4.31** - 1.72 ±5.75 
200 iig/mL 25.9 士 19.8 - 0.13 ±6.12 
100 ^ig/mL 5 . 5 3 ± 4 . 2 0 - 11.42 土 9 . 3 7 * 
50 |j,g/mL -b - _ 
25 |ig/mL - - 8.24 ±7.07 
12.5 |ig/mL - - 5.38 士 4.48 
^Data are means 士 S.D. (n=4); means are significantly different from the control group 
(Student's t test ** for /7<0.001); means are significantly different from the control 
group (Student's t test * for /7<0.05) 
inhibition observed 
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All the three extracts of lOPTR showed significant inhibition against HL-60 cells. 
At a concentration of 400 ！i g/mL , 10PTR2 showed the weakest activity while 
lOPTR-1 and 1 OPTR-2 showed inhibition of about 70 % (Table 3.12). 
Table 3.12 Inhibition ratio ( % / of hot water-soluble extracts from lOPTR on HL-60 
lOPTR-1 1 OPTR-2 1 OPTR-3 
400 ^ig/mL 7 2 . 1 士 1 4 . 4 * * 2 2 . 9 1 士 5 . 0 0 * 6 6 . 0 士 7 . 3 2 * * 
200 |ig/mL 3 6 . 9 士 1 6 . 7 * * 9.41 士 14.1 3 6 . 9 士 1 3 . 4 * 
1 0 0 iig/mL 1 1 . 2 ± 9 . 7 5 2 . 0 0 ± 1 0 . 0 22.9 士 11.7* 
50 |ig/mL -b - 16.4 ±13.4 
25 [ig/mL 3.66 士 13.2 8.97 士 7.44 0.26 士 12.2 
12.5 |ig/mL 4.76 士 14.0 1.13 士 15.5 12.9 ±6 .20 
^Data are means 士 S.D. (n=4); means are significantly different from the control group 
(Student's t test ** for /7<0.001); means are significantly different from the control 
group (Student's t test * for /K0.05) 
^ o inhibition observed 
Comparing 200PTR, 60PTR and lOPTR, it was observed that the first extract 
from all three samples demonstrated a strong inhibition of over 70 % against HL-60 
cells at high concentration. Referring to result of extraction yield (Table 3.1), the 
highest yield was achieved in the first extraction for all three samples. This indicated 
that most of the active polysaccharides against HL-60 cells were preferentially 
extracted in the first extraction. 
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3.5.1.2 In vitro antiproliferative study by THP-1 
THP-1 is acute monocytic leukemia cells. 200PTR-1 had no significant 
inhibitory effect on THP-1. However, 200PTR-2 and 200PTR-3 inhibited growth 
THP-1 cells though the inhibition was less than 50 % even at the highest 
concentration tested of 400 |ig/mL (Table 3.13). 
Table 3.13 Inhibition ratio (%f of various fractions from 200PTR on THP-1 
2Q0PTR-1 200PTR-2 200PTR-3 
400 |ig/mL -b 42.6 士 6.68** 23.2 士 12.2* 
200 jig/mL - 40.4 士 4.54** 10.0 ± 10.3 
100 |ig/mL - 33.7 士 16.6* 3.00 士 9.52 
50 ^g/mL - 27.5 士 13.9* -
25 [ig/mL - 9.71 ±12.1 -
12.5 |ig/mL - 1.41 ±9.21 -
^Data are means 士 S.D. (n二4); means are significantly different from the control group 
(Student's t test ** for /7<0.001); means are significantly different from the control 
group (Student's t test * for p<0.05) 
^No inhibition observed 
Although all extracts from 60PTR had inhibitory effect on THP-1 cells, 
inhibition effect with significant inhibition was only observed in 60PTR-1. At the 
lowest concentration (12.5 |ig/mL), 60PTR-1 showed about 40 % inihibtion against 
THP-1. It had the best effect at 100 |ig/mL at which 60 % inhibition was achieved and 
it even showed an inhibition ratio of 93 % at 400 jig/mL (Table 3.14). 
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Table 3.14 Inhibition ratio of hot water-soluble extracts from 6QPTR on THP-1 
6QPTR-1 60PTR-2 60PTR-3 
4 0 0 iig/mL 9 3 . 3 士 6 . 1 5 * * 3 4 . 3 士 4 . 3 5 2 0 . 0 士 17.3 
200 |ig/mL 71.9 士 12.7** 35.2 ± 10.42 22.6 士 12.6 
1 0 0 |ig/mL 6 0 . 4 士 7 . 4 7 * * 2 1 . 7 士 8 . 4 2 1 6 . 7 ±7.47 
50 ^ig/mL 41.6 土 14.4 39.4 士 4.76 6.57 士 8.42 
2 5 |ig/mL 4 3 . 6 ± 8 . 8 6 2 3 . 4 士 7 . 4 7 1 3 . 3 士 1 1 . 1 
12.5 |ig/mL 39.4 ± 8.47 27.6 ± 19.3 ^ 
^Data are means 士 S.D. (n=4); means are significantly different from the control group 
(Student's t test ** for /7<0.001); means are significantly different from the control 
group (Student's t test * for /?<0.05) 
� o inhibition observed 
lOPTR-1 and 1 OPTR-3 showed significant inhibition against THP-1 cells at all 
concentrations tested. At 400|ig/mL, 1 OPTR-3 had the highest activity of 77 %, 
followed by lOPTR-2 which had about 50 % inhibition. lOPTR-2 also showed 40 % 
inhibition against THP-1 cells at this high concentration (Table 3.15). 
Table 3.15 Inhibition ratio {%f of hot water-soluble extracts from lOPTR on THP-1 
lOPTR-1 lOPTR-2 1 OPTR-3 
400 |ig/mL 5 2 . 9 士 5 . 7 9 * * 4 4 . 0 士 7.77** 77.6 士 6 . 3 4 * * 
200 i^ g/mL 47.3 ± 6.73** 38.3 ± 6 .73" 55.2 ± 3.66** 
1 0 0 [ig/mL 4 0 . 6 ± 6 . 7 3 * * 3 0 . 5 ± 1 3 . 0 0 * 4 2 . 8 土 2 1 . 8 * * 
50 |ig/mL 26.0 土 5.79* 4.71 ± 18.8 41.7 士 3.66** 
25 |ig/mL 18.2 士 15.7* 36.1 ± 5.64** 23.8 ± 9.69* 
12.5 |ig/mL 31.6 士 6.85** 9.19 ±9.24 21.5 土 14.9* 
^Data are means 士 S.D. (n=4); means are significantly different from the control group 
(Student's t test ** for /7<0.001); means are significantly different from the control 
group (Student's t test * for /?<0.05) 
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3.5.1.3 In vitro antiproliferative study by MCF-7 
lOPTR-1 and lOPTR-2 showed significant inhibitory effect on adherent MCF-7 
breast cancer cells at a concentration of 50 fi g/mL. lOPTR-1 even had 35% inhibitory 
effect on growth MCF-7 at low a concentration of 25 {i g/mL (Table 3.16). 
Table 3.16 Inhibition ratio {%f of hot water-soluble extracts from lOPTR on MCF-7 
lOPTR-1 lQPTR-2 lQPTR-3 
400 |ig/mL -b 3.68 土 15.7 -
200 [ig/mL 5.55 土 12.8 6.55 土 11.3 -
100 |ig/mL 17.5 土 11.3 - 2.39 土 13.2 
50 |ig/mL 30.5 土 11.0* 15.4 土 5.62* 16.1 土 7.75 
2 5 lag/mL 34.9 土 7.6** 20.1 土 17.4 24.0 土 9.49 
12.5 iig/mL 23.4 土 9.42 11.5 土 11.2 -
^Data are means ± S.D. (n=4); means are significantly different from the control group 
(Student's t test ** for /7<0.001); means are significantly different from the control 
group (Student's t test * for /KO.05) 
bNo inhibition observed 
3.5.1.4 In vitro antiproliferative study by K562 
K562 is chronic myelogenous leukemia cells which was quite resistant. The PTR 
sclerotia extracts showed a rather weak inhibitory effect on the growth of K562, with 
most of the inhibition smaller than 20 %. Only lOPTR-1 showed a significant 
inhibition of about 30 %. 
It is within expectation that the overall growth inhibition effect was less 
significant in the K562 than in the HL-60 cells. It seemed that the chronic leukemia 
cells were more resistant to lOPTR than the acute leukemia cells. This may due to the 
different genetic make-up in the two cells. The chronic leukemia cells has 
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Philadelphia chromosome (Ph), which was originated from the reciprocal 
translocation between chromosome 9 and 22 (Nowell and Hungerford, 1960; Rowley, 
1973). This translocation caused a head-to-tail fusion of the breakpoint cluster region 
(BCR) gene on chromosome 22 with the cellular homologue of the Abelson (cABL) 
viral oncogene on chromosome 9 and result in the fused BCR-ARL oncogenes 
(Heisterkamp et al., 1985). This gene translocation was identified as one of the causes 
of the drug resistance against many kinds of anticancer drugs found in K562 
(McGahon et al., 1994). 
Table 3.17 Inhibition ratio of hot water-soluble extracts from lOPTR on K562 
lOPTR-1 lQPTR-2 lQPTR-3 
400 ^ig/mL 2 8 . 7 0 士 8 . 0 0 * 2.08 ± 5.78 -
200 |ig/mL 6.59 ± 1.76 16.97 ±8.21 -
100 ^g/mL -b 17.42 ± 8.89 5.23 ± 12.55 
50 |ig/mL 12.91 ±4.75 2.08 ± 4.27 14.71 ± 16.17 
25 |ig/mL 5.69 ± 13.93 3.43 ± 5.99 8.84 ±5.21 
12.5 [ig/mL 5.69 ± 18.17 12.45 ± 12.37 6.14 ±12.06 
^Data are means 士 S.D. (n=4); means are significantly different from the control group 
(Student's t test ** for / ? < 0 . 0 0 1 ) ; means are significantly different from the control 
group (Student's t test * for /7<0.05) 
^ o inhibition observed 
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3.5.1.2 In vitro antiproliferative study by THP-1 
S-180 is murine sarcoma cells. Only lOPTR-3 showed significant inhibition of 
40 % against S-180 at 400 ^ig/mL. lOPTR-1 and 10PTR2 only showed weak 
inhibition of lower than 20 % (Table 3.18). 
Table 3.18 Inhibition ratio {%f of hot water-soluble extracts from lOPTR-1 on SI 80 
lOPTR-1 lQPTR-2 lQPTR-3 
4 0 0 lag/mL 1 4 . 1 2 士 1 1 . 8 8 3 . 9 5 士 5 . 7 0 3 9 . 9 6 士 2 5 . 3 7 * 
200 |ig/mL 6.54 ± 13.12 11.64 ± 11.89 8.21 ±7.51 
100 |ig/mL -b 5.53 士 2.86 -
50 |ig/mL 11.34 士 12.00 - -
25 jig/mL - - -
12.5 |ig/mL -
^Data are means 士 S.D. (n=4); means are significantly different from the control group 
(Student's t test ** for /7<0.001); means are significantly different from the control 
group (Student's t test * for /;<0.05) 
^ o inhibition observed 
3.5.1.6 In vitro antiproliferative study by normal cells 
The tumor specificity of the antiproliferative activity of 200PTR-1, 200PTR-2, 
200PTR-3, 60PTR-1，60PTR-2, 60PTR-3, lOPTR-1, lOPTR-2 and lOPTR-3 was 
examined by monkey Vero cells which is normal cell lines. No cytotoxicity was 
observed at concentration from 12.5 |ag/mL to 400 |ig/mL (Data not shown). 
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3.5.1.7 Dose-response relationship between hot water-soluble extract from lOPTR 
and tumor cell inhibition 
For lOPTR-1, lOPTR-3, the increase in the concentration of extract showed a 
strong correlation with the increase in inhibition on HL-60. For lOPTR-3, the increase 
in the concentration of extract also showed a strong correlation with the increase in 
inhibition on THP-1 cells (Figure 3.5, 3.6 and 3.9). The dose of lOPTR-1 and 
1OPTR-2 was also correlated to the inhibition of THP-1 cells. (Figure 3.7 and 3.8). 
From these dose-response graph, the concentrations of extracts required for 50% 
growth inihibition (IC50) were determined (Table 3.19). The IC50 was then used as a 
reference concentration for treatment of the cell in the cell cycle analysis by flow 
cytometry (Section 3.6). 
Table 3.19 IC50 for hot water-soluble extracts from lOPTR on inhibition of 
THP-1 and HL-60 
IC50 (^ig/mL) 
THP-1 HL-60 
lOPTR-1 269.8 250.8 
1 OPTR-2 441.6 *n.d. 
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3.5.2 In vivo antitumor study of hot water-soluble extracts from lOPTR 
As shown from the in vitro study above (Section 3.5.1), lOPTR showed 
antitumor effect against murine S-180 and acute leukemia HL-60 cells. Also, since 
animal model requires large amount of sample material, the three hot water-soluble 
extracts of lOPTR with the highest activity were chosen for further study of the in 
vivo antitumor effect using BALB/c mice and athymic nude mice as animal models. 
3.5.2.1 BALB/c mice 
p=0.006* 
8 0 ————— — 
^ psO.032 T 
0 70 一 ^ - ^ — - - -
1 60 — ^ - 7 
R 5 0 — ^ ― 
I 40 
Hot water-soluble extracts of 10PTR 
Figure 3.10 In vivo antitumor effects of various hot water-soluble extracts of lOPTR 
on S-180 grown on male BALB/c mice at a dose of 20 mg/kg. Data are means ± S.D. 
(n二 10). *Means were significantly different from the control group when p<0.05 
(Student's t test) 
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All of the fractions from lOPTR showed inhibition of S-180 tumor in male 
BALB/c mice with lOPTR-3 having the strongest inhibition of 55 % (p=0.006). The 
inhibition ration of lOPTR-1 and 1 OPTR-2 were 41 % 0=0.032) and 29 %, 
respectively. The result of in vivo study agreed with that in the in vitro study, with 
lOPTR-1 and 1OPTR-3 showing a significant inhibition to Sacroma 180 cells (Figure 
3.10). The result was comparable to previous study that PTR hot water extract 
obtained from sequential extraction showed about 50 % inhibition to S-180 growth in 
BALB/c mice (Lai, 2005). It has been suggested by in vivo murine models that 
antitumor activity of fungal products was achieved not only by direct cytotoxic action 
but also by a stimulation of cell-mediated immune response which also involved host 
immune system (Wasser, 2002). This may explained why the lOPTR fractions showed 
a higher inhibition in the in vivo study than in the in vitro study. 
3.5.2.2 Athymic nude mice 
Immunodeficient mice such as athymic (nude) or severe combined immune 
deficient (SCID) are often used as animal models to study potential drugs against 
human cancers. These models are xenografts of human tumors grown subcutaneously 
in immunodeficient mice. To further demonstrate the antitumor effect of PTR sclerotia 
in human tumors, athymic nude mice model was adopted in this project to study the 
effect of micronised PTR sclerotial extract on the growth of HL-60 cells. According to 
the in vitro result (Table 3.12), lOPTR-1 and 1 OPTR-3 showed a more potent 
antiproliferative effect on HL-60 cells so they were chosen for the athymic nude mice 
study. 
8 4 
Two parameters were used to assess the antitumor effect, namely the tumor 
weight and the tumor volume (Figure 3.11 and 3.12). lOPTR-3 showed a significant 
inhibition of 38 % and 36 % for tumor weight and tumor volume, respectively. 
lOPTR-1 only showed a significant inhibition of 33 % for tumor volume. The result 
of tumor weight and tumor volume showed some difference the tumor grown on the 
nude mice differed in shape and density. 
Antitumour native mushroom polysaccharides such as schizophyllan and 
lentinan could only inhibit Sarcoma 180 in in vivo model, but have no cytotoxicity in 
vitro. On the other hand hot water fractions from PTR sclerotia exhibited antitumor 
effect to a wide range of cell lines including S-180 and HL-60 both in vivo and in 
vitro . This is quite similar to those of protein-bound polysaccharides (PSK, Krestin), 
PSP isolated from Coriolus versicolor which had both immunomodulating activites 
and direct cytotoxicity (Ooi and Liu, 2000; Yang et al” 1992). 
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Figure 3.11 In vivo antitumor effects on tumor weight inhibition of various hot 
water-soluble extracts from lOPTR on HL-60 grown on male nude mice at a dose of 
10 mg/kg. Data are means 士 S.D. (n=7). *Means were significantly different from the 
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Figure 3.12 In vivo antitumor effects on tumor volume inhibition of various hot 
water-soluble extracts from lOPTR on HL-60 grown on male nude mice at a dose of 
10 mg/kg.Data are means 士 S.D. (n=7). *Means were significantly different from the 
, control group when p<0.05 (Student's t test) 
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3.6 Flow cytometric analysis of tumor cells treated by various hot water-soluble 
extracts from lOPTR 
3.6.1 Antiproliferative effect of various hot water-soluble extracts from lOPTR on 
HL-60 
The DNA content in the cells is determined using propidium iodide (PI). 
Propridium iodide is a fluorochome that intercalates with DNA molecules. The DNA 
content in the G2/M phase of the cells is double to that of Gi phase. As the cells in S 
phase are synthesizing the DNA and about to enter mitotic phase, the DNA content is 
intermediate between those of Gi and G2/M phase. DNA fragmentation is one of the 
feature in apoptosis so the DNA content in apoptotic cells was detected as sub Gi 
peak. 
The concentration of 250 |ag/mL was chosen for cell cycle analysis of lOPTR-1 
on HL-60 since this concentration inhibited about 50 % growth of HL-60 as shown in 
the previous result (Table 3.19). As shown in below [Figure 3.13 (b), (d) and (f)], the 
sub-Gi peak, also known as apoptotic peak, corresponds to the cells undergoing 
apoptosis. The cell cycle was shown as Gi, S and G2/M peaks following the sub-Gi 
peak. 
After 24-hour incubation with lOPTR-1, there was a significant increase of 
apoptotic cells (27.73 %) compared to the control (3.19 %). [Figure 3.13 (a) and (b)]. 
When the HL-60 cells was incubated with lOPTR-1 for 48 hours, the sub Gi peak was 
still significantly higher than the control group (18.81 %) but the ratio of apoptosis 
between control and treatment group was decreased (8.7 for 24 hours and 6.9 for 48 
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hours). Besides, there was a significant increase in S peak and a concomitant decrease 
in G2/M peak [Figure 3.13 (c) and (d)] at 48-hour time point. This can be 
hypothesized that the apoptosis rate could not be maintained and certain degree of 
resistance might have been developed. Some of the cells might be able to escape from 
the apoptotic pathway, but were arrested at the S phase which was triggered after 
48-hour incubation. The cell cycle arrest could lower the proliferation rate by 
delaying entry of cells into mitosis so that DNA repair mechanism could be carried 
out. After 72-hour incubation, the percentage of apoptotic cells in treatment group 
(17.61 0/0) was still significantly higher than the control group (1.88 %) and the ratio 
of apoptosis between the treatment and control group resumed (9.4 for 72 hours), 
indicating a restore of apoptotic mechanism. A significant decrease in the Gi peak and 
increase in the S peak was observed. Arresting the cell at a particular phase of cell 
cycle allows the cell to have time to repair the damaged DNA whereas apoptosis 
eliminate the damaged cells that could not be repaired (Lu et al., 2006). This may 
indicate that the cells which could not be repaired were induced to undergo apoptosis 
after 72-hour incubation. 
Table 3.20 The proportion (Vof of HL-60 cells in different cell cycle phases treated by 
by lOPTR-1 at concentration of 250 |ig/mL 
Apoptotic cells Non-apoptotic cells (Normalised %) 
Treatment (Sub-Gl) , 
Go/Gi S G2/M 
0/0 of total cells 
24-control 32.74 32.53 ^ 
24-1 OPTR-1 2 7 . 7 3 * 37.57 33.07 29.37 
48-control 2.71 39.20 45.70 15.10 
48-1 OPTR-1 1 8 . 8 1 * 40.33 5 2 . 5 0 * 7 . 1 7 * 
72-control 1.88 41.97 40.33 17.73 
72-1 OPTR-1 1 7 . 6 1 * 3 7 . 3 0 * 4 6 . 6 0 * 16.10 
^Data are means 士 S.D. (n=3). Means were significantly different from the control 
(Student's t test, *for p<0.05, ** for p<0.001) 
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Figure 3.13 DNA histogram showing the effect of 1 OPTR-1 on the cell cycle of 
HL-60 cells. The HL-60 cells were incubated with 250 |ig/mL lOPTR-1 for (b) 24 
hours, (d) 48 hours and (f) 72 hours, respectively, comparing to their controls (a, c 
and e). Figure for Sub Gi was % of the total number of cells while figures for the 
other cell cycle phases ere normalised ones. 
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When a concentration of 300 [ig/mL of lOPTR-3 was incubated with HL-60 cells, 
significant apoptotic peak was observed at three time points (Table 3.21 and Figure 
3.14). Although without statistical significance, the percentage of cells at S phase in 
the treatment group (15.10 %) was lower than that in the control group (46.33 %) at 
24-hour time point. A concomitant increase in Gq/Gi peak and G2/M phase was 
observed. As the incubation time proceeded to 48 hours, the cell cycle could barely 
been seen [Figure 3.14 (d)]. The apoptotic peak was significantly increased to 48.40 
% and the ratio of sub-Gi peak between the treatment group to the control group was 
increased (29.2 for 24 hours to 37.8 for 48 hours). After 72-hour incubation, the cell 
cycle was totally absent and the apoptotic peak sustained (57.25 %) indicating the 
continual induction of apoptosis by lOPTR-3. 
Table 3.21 The proportion (%f of HL-60 cells in different cell cycle phases treated by 
lOPTR-3 at concentration of 300 |ig/mL 
Apoptotic cells Non-apoptotic cells (Normalised %) 
(Sub-Gl) 
Treatment Gq /Gi S G2/M 
0/0 of total cells 
24-control 33.63 46.33 20.03 
24-10PTR-3 6 7 . 2 4 * * 49.53 15.10 35.47 
48-control 1.28 38.97 44.13 16.90 
48-10PTR-3 4 8 . 4 0 * * -b - -
72-control 1.72 40.63 42.57 16.83 
72-10PTR-3 5 7 . 2 5 * - “ -
^Data are means 士 S.D. (n=3). Means were significantly different with the control 
(Student's t test, *for p<0.05, ** for pO.OOl) 
bcdl cycle was not observed 
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Figure 3.14 DNA histogram showing the effect of 1 OPTR-3 on the cell cycle of 
HL-60 cells. The HL-60 cells were incubated with 300 |ig/mL 1 OPTR-3 for (b) 24 
hours, (d) 48 hours and (f) 72 hours, respectively, comparing to their controls (a, c 
and e) Figure for Sub Gi was % of the total number of cells while figures for the other 
cell cycle phases ere normalised ones. 
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3.6.2 Antiproliferative effect of various hot water-soluble extract from lOPTR on 
THP-1 
lOPTR-1 at 270 jag/mL induced a significant 16-fold increment of apoptotic peak 
(50.07 %) and an increase of Gq/Gi phase (54.60 %) in the treatment group as 
compared to the control group in THP-1 cells at 24-hour time point. At 48-hour 
incubation time, although the cell cycle could be observed from the diagram [Figure 
3.15 (d)], the percentage of cells in the cell cycle phases could not be detected. The 
apoptotic peak increased significantly to 67.03 % and even to 76.17 % at 48-hour and 
72-hour time point, respectively. The cell cycle could not be observed from the 
diagram [Figure 3.15 (f)] at 72 hours, probably due to the extensive apoptosis. 
Table 3.22 The proportion (%f of THP-1 cells in different cell cycle phases treated 
by lOPTR-1 at concentration of 270 [ig/mL 
Apoptotic cells Non-apoptotic cells (Normalised %) 
Treatment (Sub-Gl) � � / � ^ S G,/M 
% of total cells 
24-control 44.60 
24-1 OPTR-1 50.07** 54.60* 40.70 4.70 
48-control 2.76 48.60 36.87 14.57 
48-1 OPTR-1 67.03* -b - -
72-control 2.58 45.85 14.60 39.60 
72-1 OPTR-1 76.17** - - -
^Data are means 士 S.D. (n=3). Means were significantly different with the control 
(Student's t test, *for；?<0.05, ** for JCKO.001) 
bCell cycle not observed 
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Figure 3.15 DNA histogram showing the effect of lOPTR-1 on the cell cycle of 
THP-1 cells. The THP-1 cells were incubated with 270 ^ig/mL lOPTR-1 for (b) 24 
hours, (d) 48 hours and (f) 72 hours, respectively, comparing to their controls (a, c 
and e) Figure for Sub Gi was % of the total number of cells while figures for the other 
cell cycle phases ere normalised ones. 
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From the previous result (Table 3.19), the concentration of 1 OPTR-2 (about 450 
l^g/mL) required to inhibit 50 % growth of THP-1 cells was higher than the other two 
fractions. After 24-hour incubation, there was a significant increase of sub-Gi peak 
(41.74 o/o) comparing to the control group ( 2 . 1 6 %). The Gq /Gi peak showed a 
significant increase (49.47 %) with a concomitant decrease in the S and Gi/M phase. 
It is hypothesized that the cells were induced to undergo apoptosis and accumulated at 
Go/Gi phase so that cells could not pass through the Gi phase to move on to the S and 
G2/M phase. After 48-hour, although the percentage of apoptotic cells (40.19 %) was 
lower than at 24-hour, the ratio of apoptotic cells in the treatment group to the control 
group was kept almost the same (19.3 for 24 hour and 19.5 for 48 hour) indicating 
that the apoptosis was able to be maintained at a certain level. After 72-hour 
incubation, the percentage of apoptotic cells dropped which implied that certain 
resistance was encountered and the cell death pathway could not be maintained. The 
cells escaped from apoptosis were arrested at S phase, leading to a significant increase 
in S phase and decrease in G2/M phase (Table 3.23 and Figure 3.16). 
Table 3.23 The proportion of THP-1 cells in different cell cycle phases treated 
by lOPTR-2 at concentration: 450 |ig/mL 
Apoptotic cells Non-apoptotic cells (Normalised %) 
Treatment (Sub-Gl) s G,/M 
0/0 of total cells 
24-control ^ 42.20 1 8 ^ 
24-1 OPTR-2 41.74* 49.47* 38.57* 11.97** 
48-control 2.06 46.07 37.67 16.27 
4 8 - 1 OPTR-2 40.19* 4 3 . 8 3 4 0 . 9 3 1 5 . 2 3 
72-control 2.47 43.73 39.07 17.20 
7 2 - 1 OPTR-2 3 3 . 9 2 * * 4 4 . 7 0 4 2 . 6 3 * 1 2 . 7 0 * 
^Data are means 士 S.D. (n=3). Means were significantly different with the control 
(Student's t test, *forp<0.05, ** for/?<0.001) 
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Figure 3.16 DNA histogram showing the effect of 1 OPTR-2 on the cell cycle of 
THP-1 cells. The THP-1 cells were incubated with 450 jag/ml lOPTR-1 for (b) 24 
hours, (d) 48 hours and (f) 72 hours, respectively, comparing to their controls (a, c 
and e) Figure for Sub Gi was % of the total number of cells while figures for the other 
cell cycle phases ere normalised ones. 
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1OPTR-3 at the concentration of 110 jig/mL induced more than 60 % apoptotic 
cells in THP-1 at the three time points (61.63 %, 78.47 % and 76.28 % for 24, 48 and 
72 hours, respectively) (Table 3.24). Although the G Q / G I peak could be observed from 
the diagram [Figure 3.17 (b)] at 24 hours, the percentage of cells in the other cell 
cycle phases could not be detected. Same observation was found in the treatment 
group at 48 and 72 hours [Figure 3.17 (d) and (f)]. The reason that the cell cycle could 
not be observed from the diagram is probably due to the extensive apoptosis. 
Table 3.24 The proportion of THP-1 cells in different cell cycle phases treated by 
1 OPTR-3 at concentration: 110 ^ig/mL 
Apoptotic cells Non-apoptotic cells (Normalised %) 
Treatment (Sub-Gl) s G,/M 
o/o of total cells 
24-control ^ ^ ^ T ? 
24-1 OPTR-3 61.6** -b - -
48-control 1.89 48.2 36.8 15.1 
48-1 OPTR-3 78.5** - - -
72-control 1.61 47.1 38.1 14.7 
72-1 OPTR-3 7 6 . 3 * * - - -
^Data are means 土 S.D. (n=3). Means were significantly different with the control 
(Student's t test, *for;?<0.05, ** forpO.OOl) 
bCell cycle not observed 
9 7 
- Go/G,:41.77% 1 
S: 41.67% _ I 
D I 
G./M: 16.57% - 1 
0 1023 ~ ‘ ~ ‘ ^ ^ - i H i i 
(a) 24-hour control (b) 24-hour 1OPTR-3 
Sub G,: 1.89% ' " 1 SubG丨:78.47% 
Go/G,:48.17% I 
S: 36.77% i 
- D I 
G2/M: 15.07% 1 
-3 丨 i j p a ^ ^ i i , 1023 0 1023 
(c) 48-hour control (d) 48-hour 1 OPTR-3 
SubG,: 1.61% I SubG,:76.28% 
Go/G,:47.13% I 
S: 39.13% ft 
- D Q 
G2/M： 14.73% m 
— L i I T L 
0 ‘ ‘ ‘ ^ r — ^ ~ ^ “ “ ‘ ^ ^ - [ ) 吟 竹 , — i — i — i i 
(e) 72-hour control (f) 72-hour 1 OPTR-3 
Figure 3.17 DNA histogram showing the effect of 1 OPTR-3 on the cell cycle of 
THP-1 cells. The THP-1 cells were incubated with 110 昭/mL lOPTR-1 for (b) 24 
hours, (d) 48 hours and (f) 72 hours, respectively, comparing to their controls (a, c 
and e) Figure for Sub Gi was % of the total number of cells while figures for the other 
cell cycle phases ere normalised ones. 
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3.7 Effect of various hot water-soluble extracts from lOPTR on expression of Bcl-2 
and Bax proteins in HL-60 cells 
Bcl-2 family proteins are regulators of apoptosis. Bcl-2 family includes Bax and 
Bad which are proapoptotic; and Bcl-2, Bcl-xL which are antiapoptotic. These 
proapoptotic and antiapoptotic proteins work in an antagonistic function and regulate 
the occurrence of apoptosis. 
Bcl-2 locates on the outer mitochondrial membrane to inhibit the release of 
cytochrome and is usually found to be overexpressed in many tumors while Bax 
disrupts the mitochondrial membrane (Cory and Adams, 2002). Bax/Bcl-2 ratio 
determines the susceptibility of cells to apoptosis and the therapeutic response to the 
chemotherapy (Raisova et al., 2001). 
The expression of Bcl-2 protein in HL-60 cells was lowered in a time-dependent 
manner after lOPTR-1 treatment (Figure 3.18). Although the expression of 
proapoptotic protein Bax was also lowered in a time-dependent manner, the 
Bax/Bcl-2 ratio increased in a time-dependent manner. The Bax/Bcl-2 molecule 
mediates mitochondria pathway and an increase of the Bax/Bcl-2 ratio helps to release 
apoptosis-inducing factors from mitochondria (Potten and Wilson, 2004). There was 
no obvious correlation observed between Bax/Bcl-2 ratio and the percentage of 
apoptosis in the 1 OPTR-1-treated HL-60 cells (Figure 3.18). This might be due to the 
fact that besides the mitochondrial-dependent pathway, other apoptotic pathway, such 
as death receptor-dependent pathway might be involved in triggering apoptosis in 
1 OPTR-1-treated HL-60 cells. 
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Figure 3.18 (a) The Bcl-2 and Bax expression in HL-60 cells incubated with lOPTR-1 
at 250 jig/mL for 24, 48 and 72 h with the relative density of the band measured by 
densitometer, P-actin was used as the loading control, (b) The corresponding ratio of 
the relative density of Bax/Bcl-2 in 1 OPTR-1-treated HL-60 cells. 
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3.8 Correlation between particle size, structure and antitumor activity of 
mushroom sclerotial extracts 
Mushroom polysaccharides are main source of antitumor polysaccharides. They 
are glucans with different types of glycosidic linkages, heteroglycans or bind to 
protein residues as polysaccharide-protein complexes (Wasser, 2002). Well-known 
examples such as lentinan from fruiting bodies of Lentinus edodes; schizophyllan 
from the liquid cultured medium of Schizophyllum commune; pachyman from 
sclerotia of Poria cocos are linear P-glucans with different glycosidic linkages. On the 
other hand, krestin (PSK) and polysaccharopeptide (PSP) from cultured mycelium of 
CM-101 and Cov-1 strains of Coriolus versicolor is also among the major antitumor 
drugs which resembles a polysaccharide-protein complex structure (Cui and Chisti, 
2003). 
Sclerotial powders of three different particle sizes (10 jim, 60 j^ m and 200 |im) 
were obtained by micronisation treatment and extracted for their hot water-soluble 
extracts (lOPTR, 60PTR and 200PTR). These extracts were then characterized for 
their carbohydrate contents, uronic acid contents, protein contents, monosaccharide 
profile and molecular weight (Section 3.2-3.4). The results showed that these 
sclerotial extracts had a considerable amount of protein content, ranging from 9.24% 
to 50.71% for different particle size. Therefore, they were presumably to resemble the 
structure of polysaccharide-protein complexes. 
The fungal cell walls are known to have polysaccharides and glycoproteins as the 
major components (Ruiz-Herrera, 1956). Yeast, Saccharomyces cerevisiae, contains 
P(1^3)-D-glucan, P(1^6)-D-glucan, chitin, and mannoprotein in the cell wall (Cabib 
1 0 1 
et al., 1982). It was reported that the polysaccharides served structural function while 
the mannoprotein(s) were responsible for the permeability of the cell wall (Zlotnik et 
aL, 1984; De Nobel et al., 1990). Although the carbohydrate content of these 
micronised sclerotial extracts ranged from 50.8% to 87.4%, all the polysaccharide 
moiety of the three extracts (10 |im, 60 jam and 200 jim) consisted mainly of glucose 
(>90%) (Section 3.3). Mannose was detected as a minor proportion (>10%) while 
other sugars were not present. All these hot water-soluble extracts were therefore 
proposed to have mainly homoglucan-protein structure. On the other hand, the hot 
water-soluble extracts from unmicronised 500PTR, consisting of 81.1% glucose, 
13.9% mannose and other sugars like ribose, xylose, galacotse, have a 
heteroglucan-protein structure. 
Polysaccharide-protein complex is a wide range of compounds formed with 
polysaccharides and proteins which had potent antitumor activities. Krestin (PSK) 
extracted from mycelia of Coriolus versicolor consists of 34-35 % soluble 
carbohydrate (91-93 % p-glucan) and 28-35 % protein (Ueno et al., 1980). PSP and 
PSK contain a-1,4 and P-1,3 glucosidic linkages in their polysaccharide moieties (Ng, 
1998). D-glucose is the major monosaccharide present in PSP and PSK. Arabinose 
and rhamnose are the other principal monosaccharides in PSP while. PSK contains 
fucose. Galactose, mannose, and xylose are also present (Wang et al., 1996; Cheng et 
al., 1998). PSK was approved as prescription drug used orally, intravenously or 
intraperitoneally (Yang et al., 1992). In vitro studies have revealed that PSP acts 
selectively on HL-60 leukemic cells, arresting the cell in the G-phase and inducing 
apoptosis (Hsieh et aL, 2002). Administration of polysaccharopeptides was effective 
in reducing the progression of SI80 in nude mice (Dong et al., 1996). A 
polysaccharide-protein complex extracted from Tricholoma lobayense consisted of 
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54.3 % polysaccharide and 35.9 % protein. Its monosaccharide profile revealed the 
presence of galactose, glucose, arabinose, xylose, rhamnose, fucose and mannose (Liu 
et cd., 1995; Liu et al, 1996a). It was effective in inhibiting the growth of SI80 in 
ICR and BALB/c mice (Liu et al., 1995; Liu et al., 1996b). The activities of 
heteropolysaccharides consisted of galactose, glucose, mannose and fucose were as 
strong as homoglucans indicating that the presence of heteropolysaccharides is 
important for the antitumor activity (Mizuno，1995; Zhuang et al., 1994). 
Usually mushroom polysaccharides with strong antitumor activites consisted of 
proteins and mannose e.g. mannan peptide from Lentinus edodes (Mizuno, 1999); 
Glucomannan protein complex (ATOM) and mannan protein complex (AB-FP) from 
Agaricus blazei (Ito et al, 1997). As shown in section 3.3, higher mannose content 
was associated with higher protein content in the hot water-soluble extracts in this 
project, indicating the existence of mannoprotein. Among all the extracts, 200PTR1 
had the highest mannose content of 8.73 % with protein content of 45 % showed 
significant inhibition of 99 % to cancer cell lines HL-60 (Table 3.10). On the other 
hand, 60PTR-3 which had no mannose still showed a significant inhibition at 100 
|ig/mL (Table 3.11). Therefore, mannose did not seem to be an important factor that 
determined the antitumor activity of the hot water-soluble sclerotial extracts. 
Apart from monosaccharide composition and protein content, molecular weight 
variation would also have great influence on the antitumor activities of mushroom 
polysaccharides (Ooi and Liu, 2000). In this project, due to the limitation of solubility, 
only lOPTR-1, lOPTR-2, lOPTR-3, 200PTR-1 and 200PTR-2 could be used in the 
molecular weight determination by HPLC. It was revealed that all of the extracts had 
a high molecular weight fraction (> 78.8 x lO"^  Da). The actual molecular weight of 
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this high MW fraction could not be determined from the calibration curve since it was 
larger than the largest standard P800. It is generally recognized that high molecular 
weight is more effective than those of low molecular weight (Wasser, 2002; Mizuno et 
al” 1996) and the minimum molecular weight required for effective antitumor activity 
was about 1 x lO^Da (Adachi et al., 1990). Two relatively smaller molecular weight 
fractions were also detected in 200PTR-1 and 200PTR-2. Since generally more 
mannose was detected in sclerotial extracts with larger particle size (Table 3.4), it is 
reasonable to speculate that this small molecular weight fractions, which appeared 
only in the two extracts of 200PTR but not the three extracts of lOPTR, consisted 
mainly of mannoprotein complex while the fraction of higher molecular weight 
consisted mainly of glucan-protein complex. 
From the result of Section 3.2, it was found that with a micronisation treatment 
of sclerotial powder from 500 |im to 10 jim resulted in a change in the chemical 
composition of the hot water-soluble extracts. With particle size reduced from 500 [im 
to 10 |im, the carbohydrate content increased with a concomitant decrease in protein 
content. However, the antitumor activity of extracts of lOPTR, 60PTR and 200PTR 
showed variation in different cell line models. It seemed that the difference in 
antitumor activities of these extracts could not be solely explained by particle size 
difference. The situation is more complicated as parameters like solubility, branching 
ratio, conformation variation would have great influence on their antitumor activities. 
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Chapter 4 Conclusions and Future Works 
Non-starch polysaccharides from the sclerotia of PTR are potential antitumor 
agents, and the confirmation of their curative effect to cancers would be of great 
interest both to the nutraceutical industry and to the medical field (Zhang et al, 2001). 
Micronisation is a novel technique and its application on plant material was reported 
to have a positive effect on physiochemical properties and functionality (Chau et al, 
2007c). Therefore, in this project, micronisation treatment is applied to produce PTR 
sclerotial powder of different particle size and to examine the effect of micronisation 
on the yield, chemical characteristics and antitumor activities of these mushroom 
extracts. 
Sclerotial powder of three different particle sizes (10 |im, 60 200 jim) were 
successfully produced using a ball mill and a crude grinder with different milling 
conditions (Table 2.2). When compared to the unmicronised PTR sclerotia with a 
particle size of 500 ^im, the yield of hot water-soluble extract obtained increased 
ten-fold (from 3.6% to 36.1%) when the particle size was reduced from 500 |im to 
10|im (Table 3.1). 
The particle size also had an effect on the chemical composition of hot 
water-soluble extracts obtained. With particle size reduced from 500 |im to 10 )im, the 
carbohydrate content increased while the protein decreased. All the extracts showed a 
relatively lower amount of uronic acid content. The monosaccharide profile of the 
extracts revealed that all the extracts from micronised sclerotial powder consisted of 
glucose and mannose, with glucose being the major monosaccharide (> 90%). The 
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average mannose content decreased with particle size. This agreed with the trend of 
protein content, indicating the presence of mannoprotein. 
The antitumor effect of these extracts was examined using various cell lines but 
the correlation between particle size and antitumor effect was not strong. Among the 
various fractions of different particle sizes, extracts from lOPTR had better solubility 
and higher yield. In vitro study demonstrated that extracts of lOPTR showed 
significant inhibition towards HL-60 cells. Further mechanistic studies by flow 
cytometry showed that lOPTR-1 and 1 OPTR-3 induced apoptosis and lOPTR-1 
induced S phase arrest in the cell cycle. Further study of apoptotic protein by Western 
blot revealed that the induction of apoptosis by lOPTR-1 on p53-deficent HL-60 cells 
was achieved by an elevation of the Bax/Bcl ratio. 
1 OPTR-3 showed the strongest in vitro antitumor effect in SI80 and HL-60 cells. 
The antitumor effect towards these two cell lines was further confirmed using the 
BALB/c mice and athymic mice models, respectively. This showed that sclerotial 
non-starch polysaccharides not only exert direct cytotoxicity towards cancer cell lines 
but may also have immunomodulatory effect. 
More experimental work can be done in the future. The yield of extracts obtained 
increased as particle size of the sclerotial powders decreased, possibly due to 
increased surface area and cell wall damage. The extent of mushroom cell wall 
damage can be further investigated and compared using Scanning Electron 
Microscope (SEM). 
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Hot water-soluble extracts of the micronised sclerotial powder were found to be 
effective against various cell lines in vitro and in vivo. Since the structure of these 
polysaccharide-protein complexes is important in explaining the antitumor activity, 
more effort on investigating the detailed structure is needed to establish the 
structure-activity relationship. The primary structure of a polysaccharide is defined by 
monosaccharide composition, configuration of glycosidic linkages, position of 
glycosidic linkages, sequence of monosaccharides and the nature, number and 
location of non-carbohydrate groups (Zhang et al., 2007). For future works on these 
project, effort can be done on determining the position of glycosidic linkages to see if 
(1^3)-P-glucan or other backbone linkages are present. The position of glycosidic 
linkages can be analyzed by enzyme digestion, methylation analysis and NMR 
spectroscopy. Also the different kinds of branches and the branching ratio can be 
investigated to explain the antitumor acitivity. The non-carbohydrate group in the 
polysaccharides e.g. the protein moiety, can be separated and characterized by gel 
electrophoresis method. Conformation is also an important factor which includes 
conformation of each monosaccharide, orientation of monosaccharide and flexibility 
of the spatial structure. It determines solubility and hence the activity of the 
polysaccharides. The presence of helical conformation which is important structure in 
antitumor mushroom polysaccharides can be investigated by methods such as laser 
light scattering (LLS) techniques, x-ray diffraction analysis. 
The hot water-soluble extracts, especially extracts of lOPTR which had high 
yield and showed direct cytotoxcity on various cell lines in vitro, but the detailed 
mechanisms was still not clearly understood. Future works on the mechanisms of 
apoptotic proteins and cell cycle regulatory proteins are needed. lOPTR-1 and 
1 OPTR-3 had an inhibition towards solid tumor of SI80 and HL-60 cells. The direct 
1 0 7 
tumor inhibition activity can be further investigated by immunostaining techniques 
while the immunomodulating effects can be investigated by the pattern of cytokine 
expression. 
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